In the last 12 months, insiders at Apellis Pharmaceuticals, Inc. ($APLS) filed 618 transactions with the SEC: 0 open-market purchases totaling $0 and 237 sales totaling $105,663,063. Net insider sentiment: net selling.
Apellis Pharmaceuticals, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Francois Cedric (Chief Executive Officer) — 93 transactions totaling $47,096,717
- Deschatelets Pascal (Chief Scientific Officer) — 77 transactions totaling $22,287,076
- Sullivan Timothy Eugene (Chief Financial Officer) — 65 transactions totaling $12,467,539
- Townsend Adam J. (Chief Commercial Officer) — 37 transactions totaling $11,363,543
- Dunlop A. Sinclair (Not found) — 13 transactions totaling $7,480,988
View all SEC Filings for Apellis Pharmaceuticals, Inc. (APLS).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 11, 2026 | Francois Cedric | Chief Executive Officer | G | Common Stock | 64869 | $0.00 | 1,805,259.0000 | 130,067,000 | 3.73% | 0.05% |
| March 11, 2026 | Francois Cedric | Chief Executive Officer | G | Common Stock | 64869 | $0.00 | 1,805,259.0000 | 130,067,000 | 3.47% | 0.05% |
| Feb. 27, 2026 | Dolsten Mikael | Director | A | Stock Option (Right to Buy) | 24135 | $20.96 | 24,135.0000 | 130,067,000 | 9999.99% | 0.02% |
| Feb. 27, 2026 | Dolsten Mikael | Director | A | Common Stock | 14312 | $0.00 | 14,312.0000 | 130,067,000 | 9999.99% | 0.01% |
| Feb. 11, 2026 | DeLong Mark Jeffrey | Chief Business & Strat Officer | S | Common Stock | 368 | $22.15 | 114,591.0000 | 130,067,000 | 0.32% | 0.00% |
| Feb. 3, 2026 | Francois Cedric | Chief Executive Officer | M | Common Stock | 8840 | $3.76 | 1,805,259.0000 | 130,067,000 | 0.49% | 0.01% |
| Feb. 3, 2026 | Francois Cedric | Chief Executive Officer | M | Stock Option (Right to Buy) | 8840 | $0.00 | 0.0000 | 130,067,000 | 100.00% | 0.01% |
| Jan. 28, 2026 | DeLong Mark Jeffrey | Chief Business & Strat Officer | A | Common Stock | 36606 | $0.00 | 114,959.0000 | 130,067,000 | 46.72% | 0.03% |
| Jan. 28, 2026 | Boucher Kelley | Chief People Officer | A | Common Stock | 30146 | $0.00 | 127,804.0000 | 130,067,000 | 30.87% | 0.02% |
| Jan. 28, 2026 | Chopas James George | VP/Chief Accounting Officer | A | Common Stock | 16150 | $0.00 | 65,955.0000 | 130,067,000 | 32.43% | 0.01% |
| Jan. 28, 2026 | Francois Cedric | Chief Executive Officer | A | Common Stock | 195952 | $0.00 | 1,796,419.0000 | 130,067,000 | 12.24% | 0.15% |
| Jan. 28, 2026 | Watson David O. | General Counsel | A | Common Stock | 55986 | $0.00 | 204,653.0000 | 130,067,000 | 37.66% | 0.04% |
| Jan. 28, 2026 | Sullivan Timothy Eugene | Chief Financial Officer | A | Common Stock | 58140 | $0.00 | 212,437.0000 | 130,067,000 | 37.68% | 0.04% |
| Jan. 28, 2026 | Nicholson Nur | Chief Technical Officer | A | Common Stock | 45220 | $0.00 | 116,338.0000 | 130,067,000 | 63.58% | 0.03% |
| Jan. 28, 2026 | MELTZER LESLIE | Chief Research and Development | A | Common Stock | 45220 | $0.00 | 107,024.0000 | 130,067,000 | 73.17% | 0.03% |
| Jan. 28, 2026 | Deschatelets Pascal | Chief Scientific Officer | A | Common Stock | 25840 | $0.00 | 1,177,222.0000 | 130,067,000 | 2.24% | 0.02% |
| Jan. 22, 2026 | Chopas James George | VP/Chief Accounting Officer | S | Common Stock | 2064 | $21.77 | 49,805.0000 | 130,067,000 | 3.98% | 0.00% |
| Jan. 22, 2026 | Watson David O. | General Counsel | S | Common Stock | 7832 | $21.77 | 148,667.0000 | 130,067,000 | 5.00% | 0.01% |
| Jan. 22, 2026 | Sullivan Timothy Eugene | Chief Financial Officer | S | Common Stock | 10287 | $21.77 | 154,297.0000 | 130,067,000 | 6.25% | 0.01% |
| Jan. 22, 2026 | Nicholson Nur | Chief Technical Officer | S | Common Stock | 7725 | $21.77 | 71,118.0000 | 130,067,000 | 9.80% | 0.01% |
| Jan. 22, 2026 | Francois Cedric | Chief Executive Officer | S | Common Stock | 27192 | $21.77 | 1,600,467.0000 | 130,067,000 | 1.67% | 0.02% |
| Jan. 22, 2026 | Deschatelets Pascal | Chief Scientific Officer | S | Common Stock | 5928 | $21.77 | 1,151,382.0000 | 130,067,000 | 0.51% | 0.00% |
| Jan. 22, 2026 | DeLong Mark Jeffrey | Chief Business & Strat Officer | S | Common Stock | 3371 | $21.77 | 78,353.0000 | 130,067,000 | 4.12% | 0.00% |
| Jan. 22, 2026 | Baumal Caroline | Chief Medical Officer | S | Common Stock | 2797 | $21.77 | 86,527.0000 | 130,067,000 | 3.13% | 0.00% |
| Jan. 20, 2026 | Francois Cedric | Chief Executive Officer | S | Common Stock | 8182 | $19.79 | 1,627,659.0000 | 130,067,000 | 0.50% | 0.01% |
| Jan. 20, 2026 | Watson David O. | General Counsel | S | Common Stock | 2475 | $19.79 | 156,499.0000 | 130,067,000 | 1.56% | 0.00% |
| Jan. 20, 2026 | Sullivan Timothy Eugene | Chief Financial Officer | S | Common Stock | 2892 | $19.79 | 164,584.0000 | 130,067,000 | 1.73% | 0.00% |
| Jan. 20, 2026 | Nicholson Nur | Chief Technical Officer | S | Common Stock | 2203 | $19.79 | 78,843.0000 | 130,067,000 | 2.72% | 0.00% |
| Jan. 20, 2026 | Deschatelets Pascal | Chief Scientific Officer | S | Common Stock | 909 | $19.79 | 1,157,310.0000 | 130,067,000 | 0.08% | 0.00% |
| Jan. 20, 2026 | DeLong Mark Jeffrey | Chief Business & Strat Officer | S | Common Stock | 1334 | $19.79 | 81,724.0000 | 130,067,000 | 1.61% | 0.00% |
| Jan. 20, 2026 | Chopas James George | VP/Chief Accounting Officer | S | Common Stock | 726 | $19.79 | 51,869.0000 | 130,067,000 | 1.38% | 0.00% |
| Jan. 20, 2026 | Baumal Caroline | Chief Medical Officer | S | Common Stock | 1882 | $19.79 | 89,324.0000 | 130,067,000 | 2.06% | 0.00% |
| Jan. 13, 2026 | Watson David O. | General Counsel | S | Common Stock | 5780 | $22.19 | 158,974.0000 | 130,067,000 | 3.51% | 0.00% |
| Jan. 13, 2026 | Sullivan Timothy Eugene | Chief Financial Officer | S | Common Stock | 3856 | $22.19 | 167,476.0000 | 130,067,000 | 2.25% | 0.00% |
| Jan. 13, 2026 | Deschatelets Pascal | Chief Scientific Officer | S | Common Stock | 2277 | $22.19 | 1,158,219.0000 | 130,067,000 | 0.20% | 0.00% |
| Jan. 13, 2026 | DeLong Mark Jeffrey | Chief Business & Strat Officer | S | Common Stock | 1780 | $22.19 | 83,058.0000 | 130,067,000 | 2.10% | 0.00% |
| Jan. 13, 2026 | Chopas James George | VP/Chief Accounting Officer | S | Common Stock | 873 | $22.19 | 52,595.0000 | 130,067,000 | 1.63% | 0.00% |
| Jan. 13, 2026 | Nicholson Nur | Chief Technical Officer | S | Common Stock | 2618 | $22.19 | 81,046.0000 | 130,067,000 | 3.13% | 0.00% |
| Jan. 13, 2026 | Francois Cedric | Chief Executive Officer | S | Common Stock | 10186 | $22.19 | 1,635,841.0000 | 130,067,000 | 0.62% | 0.01% |
| Jan. 7, 2026 | Watson David O. | General Counsel | M | Common Stock | 888 | $14.95 | 164,754.0000 | 130,067,000 | 0.54% | 0.00% |
| Jan. 7, 2026 | Watson David O. | General Counsel | M | Stock Option (Right to Buy) | 888 | $0.00 | 14,000.0000 | 130,067,000 | 5.96% | 0.00% |
| Jan. 5, 2026 | Baumal Caroline | Chief Medical Officer | S | Common Stock | 3020 | $25.53 | 91,206.0000 | 130,067,000 | 3.21% | 0.00% |
| Jan. 1, 2026 | Chan Gerald | Director | A | Common Stock | 7961 | $0.00 | 25,666.0000 | 130,067,000 | 44.96% | 0.01% |
| Jan. 1, 2026 | WHEELER CRAIG A | Director | A | Stock Option (Right to Buy) | 14684 | $0.00 | 14,684.0000 | 130,067,000 | 9999.99% | 0.01% |
| Jan. 1, 2026 | Machiels Alec | Director | A | Common Stock | 7961 | $0.00 | 796,939.0000 | 130,067,000 | 1.01% | 0.01% |
| Jan. 1, 2026 | Machiels Alec | Director | A | Stock Option (Right to Buy) | 14684 | $0.00 | 14,684.0000 | 130,067,000 | 9999.99% | 0.01% |
| Jan. 1, 2026 | Chan Gerald | Director | A | Stock Option (Right to Buy) | 14684 | $0.00 | 14,684.0000 | 130,067,000 | 9999.99% | 0.01% |
| Jan. 1, 2026 | WHEELER CRAIG A | Director | A | Common Stock | 7961 | $0.00 | 24,444.0000 | 130,067,000 | 48.30% | 0.01% |
| Jan. 1, 2026 | Walbert Keli | Director | A | Stock Option (Right to Buy) | 14684 | $0.00 | 14,684.0000 | 130,067,000 | 9999.99% | 0.01% |
| Jan. 1, 2026 | Walbert Keli | Director | A | Common Stock | 7961 | $0.00 | 17,051.0000 | 130,067,000 | 87.58% | 0.01% |
| Jan. 1, 2026 | FONTEYNE PAUL R. | Director | A | Stock Option (Right to Buy) | 14684 | $0.00 | 14,684.0000 | 130,067,000 | 9999.99% | 0.01% |
| Jan. 1, 2026 | FONTEYNE PAUL R. | Director | A | Common Stock | 7961 | $0.00 | 30,666.0000 | 130,067,000 | 35.06% | 0.01% |
| Jan. 1, 2026 | O'Brien Stephanie Monaghan | Director | A | Stock Option (Right to Buy) | 14684 | $0.00 | 14,684.0000 | 130,067,000 | 9999.99% | 0.01% |
| Jan. 1, 2026 | O'Brien Stephanie Monaghan | Director | A | Common Stock | 7961 | $0.00 | 25,666.0000 | 130,067,000 | 44.96% | 0.01% |
| Jan. 1, 2026 | Dunlop A. Sinclair | Director | A | Common Stock | 7961 | $0.00 | 161,567.0000 | 130,067,000 | 5.18% | 0.01% |
| Jan. 1, 2026 | Dunlop A. Sinclair | Director | A | Stock Option (Right to Buy) | 14684 | $0.00 | 14,684.0000 | 130,067,000 | 9999.99% | 0.01% |
| Dec. 16, 2025 | Watson David O. | General Counsel | S | Common Stock | 5000 | $24.49 | 163,866.0000 | 130,067,000 | 2.96% | 0.00% |
| Nov. 17, 2025 | Watson David O. | General Counsel | S | Common Stock | 5000 | $20.06 | 168,866.0000 | 130,067,000 | 2.88% | 0.00% |
| Oct. 21, 2025 | Sullivan Timothy Eugene | Chief Financial Officer | M | Common Stock | 10000 | $10.03 | 181,332.0000 | 130,067,000 | 5.84% | 0.01% |
| Oct. 21, 2025 | Sullivan Timothy Eugene | Chief Financial Officer | S | Common Stock | 10000 | $28.03 | 171,332.0000 | 130,067,000 | 5.51% | 0.01% |
| Oct. 21, 2025 | Sullivan Timothy Eugene | Chief Financial Officer | M | Stock Option (Right to Buy) | 10000 | $0.00 | 232,903.0000 | 130,067,000 | 4.12% | 0.01% |
| Oct. 16, 2025 | Watson David O. | General Counsel | S | Common Stock | 5000 | $25.22 | 173,866.0000 | 130,067,000 | 2.80% | 0.00% |
| June 24, 2025 | Dunlop A. Sinclair | Not found | J | Common Stock | 4787 | $0.00 | 153,606.0000 | 123,905,000 | 3.02% | 0.00% |
| Oct. 10, 2025 | Dunlop A. Sinclair | Not found | S | Common Stock | 31092 | $23.72 | 157,443.0000 | 130,067,000 | 16.49% | 0.02% |
| Oct. 10, 2025 | Dunlop A. Sinclair | Not found | J | Common Stock | 3837 | $0.00 | 153,606.0000 | 130,067,000 | 2.44% | 0.00% |
| Sept. 30, 2025 | Dunlop A. Sinclair | Not found | J | Common Stock | 3837 | $0.00 | 188,535.0000 | 123,905,000 | 1.99% | 0.00% |
| Sept. 30, 2025 | Dunlop A. Sinclair | Not found | S | Common Stock | 31092 | $22.58 | 192,372.0000 | 123,905,000 | 13.91% | 0.03% |
| Sept. 19, 2025 | Dunlop A. Sinclair | Not found | S | Common Stock | 31092 | $22.95 | 227,301.0000 | 123,905,000 | 12.03% | 0.03% |
| Sept. 19, 2025 | Dunlop A. Sinclair | Not found | J | Common Stock | 3837 | $0.00 | 223,464.0000 | 123,905,000 | 1.69% | 0.00% |
| Sept. 16, 2025 | Watson David O. | General Counsel | S | Common Stock | 5000 | $24.34 | 178,866.0000 | 123,905,000 | 2.72% | 0.00% |
| Sept. 15, 2025 | Chopas James George | VP/Chief Accounting Officer | S | Common Stock | 189 | $24.19 | 53,468.0000 | 123,905,000 | 0.35% | 0.00% |
| Sept. 10, 2025 | Watson David O. | General Counsel | S | Common Stock | 20000 | $26.17 | 183,866.0000 | 123,905,000 | 9.81% | 0.02% |
| Sept. 8, 2025 | Sullivan Timothy Eugene | Chief Financial Officer | S | Common Stock | 10000 | $27.83 | 171,332.0000 | 123,905,000 | 5.51% | 0.01% |
| Sept. 8, 2025 | Sullivan Timothy Eugene | Chief Financial Officer | M | Stock Option (Right to Buy) | 15000 | $0.00 | 242,903.0000 | 123,905,000 | 5.82% | 0.01% |
| Sept. 8, 2025 | Sullivan Timothy Eugene | Chief Financial Officer | M | Common Stock | 15000 | $10.03 | 204,061.0000 | 123,905,000 | 7.93% | 0.01% |
| Sept. 8, 2025 | Sullivan Timothy Eugene | Chief Financial Officer | S | Common Stock | 32729 | $27.86 | 171,332.0000 | 123,905,000 | 16.04% | 0.03% |
| Sept. 2, 2025 | Boucher Kelley | Chief People Officer | A | Common Stock | 30476 | $0.00 | 97,658.0000 | 123,905,000 | 45.36% | 0.02% |
| Sept. 2, 2025 | Chopas James George | VP/Chief Accounting Officer | S | Common Stock | 548 | $28.08 | 53,657.0000 | 123,905,000 | 1.01% | 0.00% |
| Sept. 2, 2025 | Boucher Kelley | Chief People Officer | A | Stock Option (Right to Buy) | 45766 | $0.00 | 45,766.0000 | 123,905,000 | 9999.99% | 0.04% |
| Aug. 26, 2025 | MELTZER LESLIE | Chief Research and Development | A | Common Stock | 61804 | $0.00 | 61,804.0000 | 123,905,000 | 9999.99% | 0.05% |
| Aug. 26, 2025 | MELTZER LESLIE | Chief Research and Development | A | Stock Option (Right to Buy) | 92592 | $0.00 | 92,592.0000 | 123,905,000 | 9999.99% | 0.07% |
| Aug. 28, 2025 | Francois Cedric | Chief Executive Officer | S | Common Stock | 49963 | $28.39 | 1,646,027.0000 | 123,905,000 | 2.95% | 0.04% |
| Aug. 27, 2025 | Francois Cedric | Chief Executive Officer | S | Common Stock | 175037 | $28.19 | 1,695,990.0000 | 123,905,000 | 9.36% | 0.14% |
| Aug. 18, 2025 | Watson David O. | General Counsel | S | Common Stock | 5000 | $27.80 | 203,866.0000 | 123,905,000 | 2.39% | 0.00% |
| July 17, 2025 | Francois Cedric | Chief Executive Officer | M | Stock Option (Right to Buy) | 8997 | $0.00 | 100,538.0000 | 123,905,000 | 8.21% | 0.01% |
| July 17, 2025 | Francois Cedric | Chief Executive Officer | M | Common Stock | 8997 | $4.31 | 1,890,752.0000 | 123,905,000 | 0.48% | 0.01% |
| July 16, 2025 | Watson David O. | General Counsel | S | Common Stock | 5000 | $19.55 | 208,866.0000 | 123,905,000 | 2.34% | 0.00% |
| July 17, 2025 | Francois Cedric | Chief Executive Officer | S | Common Stock | 19725 | $20.21 | 1,871,027.0000 | 123,905,000 | 1.04% | 0.02% |
| July 15, 2025 | Francois Cedric | Chief Executive Officer | M | Stock Option (Right to Buy) | 800 | $0.00 | 109,535.0000 | 123,905,000 | 0.73% | 0.00% |
| July 15, 2025 | Francois Cedric | Chief Executive Officer | S | Common Stock | 1900 | $20.09 | 1,881,755.0000 | 123,905,000 | 0.10% | 0.00% |
| July 15, 2025 | Francois Cedric | Chief Executive Officer | M | Common Stock | 800 | $4.31 | 1,883,655.0000 | 123,905,000 | 0.04% | 0.00% |
| July 14, 2025 | Francois Cedric | Chief Executive Officer | S | Common Stock | 137465 | $20.19 | 1,882,855.0000 | 123,905,000 | 6.80% | 0.11% |
| July 14, 2025 | Francois Cedric | Chief Executive Officer | M | Common Stock | 65203 | $4.31 | 2,020,320.0000 | 123,905,000 | 3.33% | 0.05% |
| July 14, 2025 | Francois Cedric | Chief Executive Officer | M | Stock Option (Right to Buy) | 65203 | $0.00 | 110,335.0000 | 123,905,000 | 37.14% | 0.05% |
| June 18, 2025 | Chopas James George | VP/Chief Accounting Officer | A | Common Stock | 6250 | $0.00 | 54,205.0000 | 123,905,000 | 13.03% | 0.01% |
| June 16, 2025 | Watson David O. | General Counsel | S | Common Stock | 5000 | $18.77 | 213,866.0000 | 123,905,000 | 2.28% | 0.00% |
| June 9, 2025 | Boucher Kelley | Chief People Officer | A | Stock Option (Right to Buy) | 67396 | $19.39 | 67,396.0000 | 123,905,000 | 9999.99% | 0.05% |
| June 9, 2025 | DeLong Mark Jeffrey | Chief Business & Strat Officer | A | Stock Option (Right to Buy) | 82500 | $19.39 | 82,500.0000 | 123,905,000 | 9999.99% | 0.07% |
| June 9, 2025 | Chopas James George | VP/Chief Accounting Officer | A | Stock Option (Right to Buy) | 11250 | $19.39 | 11,250.0000 | 123,905,000 | 9999.99% | 0.01% |
| June 9, 2025 | Baumal Caroline | Chief Medical Officer | A | Stock Option (Right to Buy) | 82500 | $19.39 | 82,500.0000 | 123,905,000 | 9999.99% | 0.07% |
| June 9, 2025 | Deschatelets Pascal | Chief Scientific Officer | A | Stock Option (Right to Buy) | 82500 | $19.39 | 82,500.0000 | 123,905,000 | 9999.99% | 0.07% |
| June 9, 2025 | Sullivan Timothy Eugene | Chief Financial Officer | A | Stock Option (Right to Buy) | 82500 | $19.39 | 82,500.0000 | 123,905,000 | 9999.99% | 0.07% |
| June 9, 2025 | Francois Cedric | Chief Executive Officer | A | Stock Option (Right to Buy) | 287500 | $19.39 | 287,500.0000 | 123,905,000 | 9999.99% | 0.23% |
| June 9, 2025 | Nicholson Nur | Chief Technical Officer | A | Stock Option (Right to Buy) | 82500 | $19.39 | 82,500.0000 | 123,905,000 | 9999.99% | 0.07% |
| June 9, 2025 | Watson David O. | General Counsel | A | Stock Option (Right to Buy) | 82500 | $19.39 | 82,500.0000 | 123,905,000 | 9999.99% | 0.07% |
| June 9, 2025 | Boucher Kelley | Chief People Officer | A | Common Stock | 45095 | $0.00 | 67,182.0000 | 123,905,000 | 204.17% | 0.04% |
| May 28, 2025 | Boucher Kelley | Chief People Officer | A | Common Stock | 22087 | $0.00 | 22,087.0000 | 123,905,000 | 9999.99% | 0.02% |
| May 28, 2025 | Boucher Kelley | Chief People Officer | A | Stock Option (Right to Buy) | 32976 | $16.80 | 32,976.0000 | 123,905,000 | 9999.99% | 0.03% |
| May 21, 2025 | Deschatelets Pascal | Chief Scientific Officer | M | Common Stock | 12780 | $3.76 | 1,160,496.0000 | 123,905,000 | 1.11% | 0.01% |
| May 21, 2025 | Deschatelets Pascal | Chief Scientific Officer | M | Stock Option (Right to Buy) | 12780 | $0.00 | 0.0000 | 123,905,000 | 100.00% | 0.01% |
| April 17, 2025 | WHEELER CRAIG A | Director | A | Common Stock | 16483 | $0.00 | 16,483.0000 | 123,905,000 | 9999.99% | 0.01% |
| April 17, 2025 | WHEELER CRAIG A | Director | A | Stock Option (Right to Buy) | 28195 | $18.20 | 28,195.0000 | 123,905,000 | 9999.99% | 0.02% |
| March 17, 2025 | Chopas James George | VP/Chief Accounting Officer | S | Common Stock | 183 | $24.82 | 47,955.0000 | 123,905,000 | 0.38% | 0.00% |
| March 4, 2025 | Watson David O. | General Counsel | G | Common Stock | 6667 | $0.00 | 218,866.0000 | 123,905,000 | 2.96% | 0.01% |
| March 4, 2025 | Watson David O. | General Counsel | G | Common Stock | 6667 | $0.00 | 218,866.0000 | 123,905,000 | 3.14% | 0.01% |
| March 5, 2025 | Watson David O. | General Counsel | S | Common Stock | 5569 | $25.10 | 218,866.0000 | 123,905,000 | 2.48% | 0.00% |
| Feb. 11, 2025 | DeLong Mark Jeffrey | Chief Business & Strat Officer | S | Common Stock | 363 | $28.54 | 83,945.0000 | 123,905,000 | 0.43% | 0.00% |
| Jan. 29, 2025 | Watson David O. | General Counsel | S | Common Stock | 695 | $29.52 | 224,435.0000 | 123,905,000 | 0.31% | 0.00% |
| Jan. 29, 2025 | Townsend Adam J. | Chief Commercial Officer | S | Common Stock | 695 | $29.52 | 84,050.0000 | 123,905,000 | 0.82% | 0.00% |
| Jan. 29, 2025 | Sullivan Timothy Eugene | Chief Financial Officer | S | Common Stock | 546 | $29.52 | 199,061.0000 | 123,905,000 | 0.27% | 0.00% |
| Jan. 29, 2025 | Nicholson Nur | Chief Technical Officer | S | Common Stock | 825 | $29.52 | 83,664.0000 | 123,905,000 | 0.98% | 0.00% |
| Jan. 29, 2025 | Lewis Karen | Chief People Officer | S | Common Stock | 364 | $29.52 | 70,251.0000 | 123,905,000 | 0.52% | 0.00% |
| Jan. 29, 2025 | Eisele Jeffrey | Chief Development Officer | S | Common Stock | 278 | $29.52 | 55,312.0000 | 123,905,000 | 0.50% | 0.00% |
| Jan. 29, 2025 | Deschatelets Pascal | Chief Scientific Officer | S | Common Stock | 826 | $29.52 | 1,147,716.0000 | 123,905,000 | 0.07% | 0.00% |
| Jan. 29, 2025 | Francois Cedric | Chief Executive Officer | S | Common Stock | 2824 | $29.52 | 1,955,117.0000 | 123,905,000 | 0.14% | 0.00% |
| Jan. 29, 2025 | DeLong Mark Jeffrey | Chief Business & Strat Officer | S | Common Stock | 365 | $29.52 | 84,308.0000 | 123,905,000 | 0.43% | 0.00% |
| Jan. 22, 2025 | Sullivan Timothy Eugene | Chief Financial Officer | S | Common Stock | 3088 | $30.43 | 199,607.0000 | 123,905,000 | 1.52% | 0.00% |
| Jan. 22, 2025 | Watson David O. | General Counsel | S | Common Stock | 3323 | $30.43 | 225,130.0000 | 123,905,000 | 1.45% | 0.00% |
| Jan. 22, 2025 | Townsend Adam J. | Chief Commercial Officer | S | Common Stock | 3323 | $30.43 | 84,745.0000 | 123,905,000 | 3.77% | 0.00% |
| Jan. 22, 2025 | Nicholson Nur | Chief Technical Officer | S | Common Stock | 3948 | $30.43 | 84,489.0000 | 123,905,000 | 4.46% | 0.00% |
| Jan. 22, 2025 | Lewis Karen | Chief People Officer | S | Common Stock | 1751 | $30.43 | 70,615.0000 | 123,905,000 | 2.42% | 0.00% |
| Jan. 22, 2025 | Francois Cedric | Chief Executive Officer | S | Common Stock | 13551 | $30.43 | 1,957,941.0000 | 123,905,000 | 0.69% | 0.01% |
| Jan. 22, 2025 | Eisele Jeffrey | Chief Development Officer | S | Common Stock | 1291 | $30.43 | 55,590.0000 | 123,905,000 | 2.27% | 0.00% |
| Jan. 22, 2025 | Deschatelets Pascal | Chief Scientific Officer | S | Common Stock | 3948 | $30.43 | 1,148,542.0000 | 123,905,000 | 0.34% | 0.00% |
| Jan. 22, 2025 | DeLong Mark Jeffrey | Chief Business & Strat Officer | S | Common Stock | 1396 | $30.43 | 84,673.0000 | 123,905,000 | 1.62% | 0.00% |
| Jan. 22, 2025 | Chopas James George | VP/Chief Accounting Officer | S | Common Stock | 1096 | $30.43 | 48,138.0000 | 123,905,000 | 2.23% | 0.00% |
| Jan. 17, 2025 | Watson David O. | General Counsel | S | Common Stock | 2201 | $29.96 | 185,691.0000 | 123,905,000 | 1.17% | 0.00% |
| Jan. 21, 2025 | Baumal Caroline | Chief Medical Officer | A | Common Stock | 39594 | $0.00 | 93,301.3700 | 123,905,000 | 73.72% | 0.03% |
| Jan. 17, 2025 | Baumal Caroline | Chief Medical Officer | S | Common Stock | 1853 | $29.96 | 53,707.3700 | 123,905,000 | 3.34% | 0.00% |
| Jan. 21, 2025 | Chopas James George | VP/Chief Accounting Officer | A | Common Stock | 12591 | $0.00 | 49,234.0000 | 123,905,000 | 34.36% | 0.01% |
| Jan. 17, 2025 | Chopas James George | VP/Chief Accounting Officer | S | Common Stock | 715 | $29.96 | 36,643.0000 | 123,905,000 | 1.91% | 0.00% |
| Jan. 21, 2025 | DeLong Mark Jeffrey | Chief Business & Strat Officer | A | Common Stock | 28508 | $0.00 | 86,069.0000 | 123,905,000 | 49.53% | 0.02% |
| Jan. 17, 2025 | DeLong Mark Jeffrey | Chief Business & Strat Officer | S | Common Stock | 1235 | $29.96 | 57,561.0000 | 123,905,000 | 2.10% | 0.00% |
| Jan. 21, 2025 | Deschatelets Pascal | Chief Scientific Officer | A | Common Stock | 15045 | $0.00 | 1,152,490.0000 | 123,905,000 | 1.32% | 0.01% |
| Jan. 17, 2025 | Deschatelets Pascal | Chief Scientific Officer | S | Common Stock | 750 | $29.96 | 1,137,445.0000 | 123,905,000 | 0.07% | 0.00% |
| Jan. 21, 2025 | Francois Cedric | Chief Executive Officer | A | Common Stock | 130662 | $0.00 | 1,971,492.0000 | 123,905,000 | 7.10% | 0.11% |
| Jan. 17, 2025 | Francois Cedric | Chief Executive Officer | S | Common Stock | 6007 | $29.96 | 1,840,830.0000 | 123,905,000 | 0.33% | 0.00% |
| Jan. 21, 2025 | Lewis Karen | Chief People Officer | A | Common Stock | 28508 | $0.00 | 72,366.0000 | 123,905,000 | 65.00% | 0.02% |
| Jan. 17, 2025 | Lewis Karen | Chief People Officer | S | Common Stock | 1241 | $29.96 | 43,858.0000 | 123,905,000 | 2.75% | 0.00% |
| Jan. 21, 2025 | Nicholson Nur | Chief Technical Officer | A | Common Stock | 36426 | $0.00 | 88,437.0000 | 123,905,000 | 70.04% | 0.03% |
| Jan. 17, 2025 | Nicholson Nur | Chief Technical Officer | S | Common Stock | 2145 | $29.96 | 52,011.0000 | 123,905,000 | 3.96% | 0.00% |
| Jan. 21, 2025 | Sullivan Timothy Eugene | Chief Financial Officer | A | Common Stock | 45929 | $0.00 | 202,695.0000 | 123,905,000 | 29.30% | 0.04% |
| Jan. 17, 2025 | Sullivan Timothy Eugene | Chief Financial Officer | S | Common Stock | 1730 | $29.96 | 156,766.0000 | 123,905,000 | 1.09% | 0.00% |
| Jan. 17, 2025 | Townsend Adam J. | Chief Commercial Officer | S | Common Stock | 2201 | $29.96 | 88,068.0000 | 123,905,000 | 2.44% | 0.00% |
| Jan. 21, 2025 | Watson David O. | General Counsel | A | Common Stock | 42762 | $0.00 | 228,453.0000 | 123,905,000 | 23.03% | 0.03% |
| Jan. 13, 2025 | Francois Cedric | Chief Executive Officer | S | Common Stock | 6247 | $28.70 | 1,846,837.0000 | 123,905,000 | 0.34% | 0.01% |
| Jan. 13, 2025 | Watson David O. | General Counsel | S | Common Stock | 4965 | $28.70 | 187,892.0000 | 123,905,000 | 2.57% | 0.00% |
| Jan. 13, 2025 | Townsend Adam J. | Chief Commercial Officer | S | Common Stock | 2685 | $28.70 | 90,269.0000 | 123,905,000 | 2.89% | 0.00% |
| Jan. 13, 2025 | Sullivan Timothy Eugene | Chief Financial Officer | S | Common Stock | 2170 | $28.70 | 158,496.0000 | 123,905,000 | 1.35% | 0.00% |
| Jan. 13, 2025 | Nicholson Nur | Chief Technical Officer | S | Common Stock | 2632 | $28.70 | 54,156.0000 | 123,905,000 | 4.63% | 0.00% |
| Jan. 13, 2025 | Lewis Karen | Chief People Officer | S | Common Stock | 1599 | $28.70 | 45,099.0000 | 123,905,000 | 3.42% | 0.00% |
| Jan. 13, 2025 | Eisele Jeffrey | Chief Development Officer | S | Common Stock | 264 | $28.70 | 56,881.0000 | 123,905,000 | 0.46% | 0.00% |
| Jan. 13, 2025 | Deschatelets Pascal | Chief Scientific Officer | S | Common Stock | 2288 | $28.70 | 1,138,195.0000 | 123,905,000 | 0.20% | 0.00% |
| Jan. 13, 2025 | DeLong Mark Jeffrey | Chief Business & Strat Officer | S | Common Stock | 1599 | $28.70 | 58,796.0000 | 123,905,000 | 2.65% | 0.00% |
| Jan. 13, 2025 | Chopas James George | VP/Chief Accounting Officer | S | Common Stock | 783 | $28.70 | 37,358.0000 | 123,905,000 | 2.05% | 0.00% |
| Jan. 8, 2025 | Walbert Keli | Director | A | Common Stock | 9090 | $0.00 | 9,090.0000 | 123,905,000 | 9999.99% | 0.01% |
| Jan. 8, 2025 | Walbert Keli | Director | A | Stock Option (Right to Buy) | 15388 | $33.00 | 15,388.0000 | 123,905,000 | 9999.99% | 0.01% |
| Jan. 6, 2025 | Baumal Caroline | Chief Medical Officer | S | Common Stock | 2816 | $33.81 | 55,560.3700 | 123,905,000 | 4.82% | 0.00% |
| Dec. 31, 2024 | Sullivan Timothy Eugene | Chief Financial Officer | M | Stock Option (Right to Buy) | 10054 | $0.00 | 84,946.0000 | 124,234,000 | 10.58% | 0.01% |
| Dec. 31, 2024 | Sullivan Timothy Eugene | Chief Financial Officer | M | Common Stock | 1042 | $14.95 | 150,612.0000 | 124,234,000 | 0.70% | 0.00% |
| Dec. 31, 2024 | Sullivan Timothy Eugene | Chief Financial Officer | M | Common Stock | 10054 | $13.85 | 160,666.0000 | 124,234,000 | 6.68% | 0.01% |
| Dec. 31, 2024 | Sullivan Timothy Eugene | Chief Financial Officer | M | Stock Option (Right to Buy) | 1042 | $0.00 | 23,958.0000 | 124,234,000 | 4.17% | 0.00% |
| Jan. 1, 2025 | O'Brien Stephanie Monaghan | Director | A | Common Stock | 6267 | $0.00 | 17,705.0000 | 123,905,000 | 54.79% | 0.01% |
| Jan. 1, 2025 | Chan Gerald | Director | A | Stock Option (Right to Buy) | 11199 | $0.00 | 11,199.0000 | 123,905,000 | 9999.99% | 0.01% |
| Jan. 1, 2025 | Chan Gerald | Director | A | Common Stock | 6267 | $0.00 | 17,705.0000 | 123,905,000 | 54.79% | 0.01% |
| Jan. 1, 2025 | Dunlop A. Sinclair | Director | A | Stock Option (Right to Buy) | 11199 | $0.00 | 11,199.0000 | 123,905,000 | 9999.99% | 0.01% |
| Jan. 1, 2025 | Dunlop A. Sinclair | Director | A | Common Stock | 6267 | $0.00 | 258,393.0000 | 123,905,000 | 2.49% | 0.01% |
| Jan. 1, 2025 | FONTEYNE PAUL R. | Director | A | Stock Option (Right to Buy) | 11199 | $0.00 | 11,199.0000 | 123,905,000 | 9999.99% | 0.01% |
| Jan. 1, 2025 | FONTEYNE PAUL R. | Director | A | Common Stock | 6267 | $0.00 | 22,705.0000 | 123,905,000 | 38.13% | 0.01% |
| Jan. 1, 2025 | Machiels Alec | Director | A | Stock Option (Right to Buy) | 11199 | $0.00 | 11,199.0000 | 123,905,000 | 9999.99% | 0.01% |
| Jan. 1, 2025 | Machiels Alec | Director | A | Common Stock | 6267 | $0.00 | 788,978.0000 | 123,905,000 | 0.80% | 0.01% |
| Jan. 1, 2025 | O'Brien Stephanie Monaghan | Director | A | Stock Option (Right to Buy) | 11199 | $0.00 | 11,199.0000 | 123,905,000 | 9999.99% | 0.01% |
| Dec. 23, 2024 | Eisele Jeffrey | Chief Development Officer | S | Common Stock | 63 | $33.09 | 57,145.0000 | 124,234,000 | 0.11% | 0.00% |
| Dec. 11, 2024 | Watson David O. | General Counsel | S | Common Stock | 5000 | $34.24 | 192,857.0000 | 124,234,000 | 2.53% | 0.00% |
| Nov. 1, 2024 | Francois Cedric | Chief Executive Officer | J | Common Stock | 182146 | $0.00 | 1,853,084.0000 | 124,234,000 | 8.95% | 0.15% |
| Sept. 27, 2024 | Watson David O. | General Counsel | G | Common Stock | 10569 | $0.00 | 197,857.0000 | 118,678,000 | 5.07% | 0.01% |
| Sept. 27, 2024 | Watson David O. | General Counsel | G | Common Stock | 10569 | $0.00 | 197,857.0000 | 118,678,000 | 5.64% | 0.01% |
| Sept. 23, 2024 | Dunlop A. Sinclair | Director | M | Stock Option (Right to Buy) | 4600 | $0.00 | 0.0000 | 118,678,000 | 100.00% | 0.00% |
| Sept. 23, 2024 | Dunlop A. Sinclair | Director | M | Common Stock | 4600 | $13.19 | 252,126.0000 | 118,678,000 | 1.86% | 0.00% |
| Sept. 16, 2024 | Dunlop A. Sinclair | Not found | S | Common Stock | 7524 | $36.79 | 247,526.0000 | 118,678,000 | 2.95% | 0.01% |
| Sept. 16, 2024 | Chopas James George | VP/Chief Accounting Officer | S | Common Stock | 192 | $36.21 | 38,141.0000 | 118,678,000 | 0.50% | 0.00% |
| Sept. 16, 2024 | Dunlop A. Sinclair | Not found | S | Common Stock | 29476 | $36.09 | 255,050.0000 | 118,678,000 | 10.36% | 0.02% |
| Sept. 3, 2024 | Chopas James George | VP/Chief Accounting Officer | S | Common Stock | 550 | $39.49 | 38,333.0000 | 118,678,000 | 1.41% | 0.00% |
| Aug. 12, 2024 | DeLong Mark Jeffrey | Chief Business & Strat Officer | M | Stock Option (Right to Buy) | 5201 | $0.00 | 14,799.0000 | 118,678,000 | 26.01% | 0.00% |
| Aug. 12, 2024 | DeLong Mark Jeffrey | Chief Business & Strat Officer | M | Common Stock | 5201 | $13.85 | 60,395.0000 | 118,678,000 | 9.42% | 0.00% |
| June 28, 2024 | Dunlop A. Sinclair | Director | M | Common Stock | 900 | $13.19 | 303,271.0000 | 118,678,000 | 0.30% | 0.00% |
| June 28, 2024 | Dunlop A. Sinclair | Director | M | Stock Option (Right to Buy) | 900 | $0.00 | 4,600.0000 | 118,678,000 | 16.36% | 0.00% |
| June 21, 2024 | Dunlop A. Sinclair | Not found | S | Common Stock | 1695 | $39.63 | 302,371.0000 | 118,678,000 | 0.56% | 0.00% |
| June 21, 2024 | Dunlop A. Sinclair | Not found | S | Common Stock | 35305 | $39.22 | 304,066.0000 | 118,678,000 | 10.40% | 0.03% |
| May 20, 2024 | Deschatelets Pascal | Chief Scientific Officer | M | Common Stock | 24500 | $3.76 | 1,140,483.0000 | 118,678,000 | 2.20% | 0.02% |
| May 20, 2024 | Deschatelets Pascal | Chief Scientific Officer | M | Stock Option (Right to Buy) | 24500 | $0.00 | 12,780.0000 | 118,678,000 | 65.72% | 0.02% |
| May 8, 2024 | Deschatelets Pascal | Chief Scientific Officer | M | Common Stock | 78907 | $4.31 | 1,194,890.0000 | 118,678,000 | 7.07% | 0.07% |
| May 8, 2024 | Deschatelets Pascal | Chief Scientific Officer | S | Common Stock | 100 | $44.03 | 1,115,983.0000 | 118,678,000 | 0.01% | 0.00% |
| May 8, 2024 | Deschatelets Pascal | Chief Scientific Officer | S | Common Stock | 22472 | $42.85 | 1,116,083.0000 | 118,678,000 | 1.97% | 0.02% |
| May 8, 2024 | Deschatelets Pascal | Chief Scientific Officer | M | Stock Option (Right to Buy) | 78907 | $0.00 | 108,622.0000 | 118,678,000 | 42.08% | 0.07% |
| May 8, 2024 | Deschatelets Pascal | Chief Scientific Officer | S | Common Stock | 56335 | $42.15 | 1,138,555.0000 | 118,678,000 | 4.71% | 0.05% |
| April 18, 2024 | Sullivan Timothy Eugene | Chief Financial Officer | G | Common Stock | 14164 | $0.00 | 149,570.0000 | 118,678,000 | 8.65% | 0.01% |
| April 18, 2024 | Sullivan Timothy Eugene | Chief Financial Officer | G | Common Stock | 14164 | $0.00 | 149,570.0000 | 118,678,000 | 10.46% | 0.01% |
| April 12, 2024 | Dunlop A. Sinclair | Director | M | Stock Option (Right to Buy) | 1500 | $0.00 | 5,500.0000 | 118,678,000 | 21.43% | 0.00% |
| April 12, 2024 | Dunlop A. Sinclair | Director | M | Common Stock | 1500 | $13.19 | 339,371.0000 | 118,678,000 | 0.44% | 0.00% |
| April 8, 2024 | Deschatelets Pascal | Chief Scientific Officer | M | Common Stock | 69107 | $3.76 | 1,185,090.0000 | 118,678,000 | 6.19% | 0.06% |
| April 8, 2024 | Deschatelets Pascal | Chief Scientific Officer | S | Common Stock | 4728 | $54.92 | 1,115,983.0000 | 118,678,000 | 0.42% | 0.00% |
| April 8, 2024 | Deschatelets Pascal | Chief Scientific Officer | M | Stock Option (Right to Buy) | 69107 | $0.00 | 37,280.0000 | 118,678,000 | 64.96% | 0.06% |
| April 8, 2024 | Deschatelets Pascal | Chief Scientific Officer | S | Common Stock | 64379 | $54.12 | 1,120,711.0000 | 118,678,000 | 5.43% | 0.05% |
| April 1, 2024 | Sullivan Timothy Eugene | Chief Financial Officer | S | Common Stock | 4000 | $58.66 | 149,570.0000 | 118,678,000 | 2.60% | 0.00% |
| April 1, 2024 | Sullivan Timothy Eugene | Chief Financial Officer | M | Common Stock | 4000 | $10.03 | 153,570.0000 | 118,678,000 | 2.67% | 0.00% |
| April 1, 2024 | Sullivan Timothy Eugene | Chief Financial Officer | M | Stock Option (Right to Buy) | 4000 | $0.00 | 257,903.0000 | 118,678,000 | 1.53% | 0.00% |
| March 19, 2024 | Dunlop A. Sinclair | Not found | S | Common Stock | 18681 | $57.18 | 337,871.0000 | 118,678,000 | 5.24% | 0.02% |
| March 18, 2024 | DeLong Mark Jeffrey | Chief Business & Strat Officer | S | Common Stock | 9913 | $56.90 | 54,693.0000 | 118,678,000 | 15.34% | 0.01% |
| March 15, 2024 | Chopas James George | VP/Chief Accounting Officer | S | Common Stock | 184 | $56.46 | 38,883.0000 | 118,678,000 | 0.47% | 0.00% |
| March 13, 2024 | Nicholson Nur | Chief Technical Officer | S | Common Stock | 3452 | $58.13 | 56,287.0000 | 118,678,000 | 5.78% | 0.00% |
| March 13, 2024 | Nicholson Nur | Chief Technical Officer | S | Common Stock | 7768 | $57.31 | 59,739.0000 | 118,678,000 | 11.51% | 0.01% |
| March 8, 2024 | Deschatelets Pascal | Chief Scientific Officer | S | Common Stock | 100 | $63.35 | 1,115,983.0000 | 118,678,000 | 0.01% | 0.00% |
| March 8, 2024 | Deschatelets Pascal | Chief Scientific Officer | M | Common Stock | 69107 | $3.67 | 1,185,090.0000 | 118,678,000 | 6.19% | 0.06% |
| March 8, 2024 | Deschatelets Pascal | Chief Scientific Officer | M | Stock Option (Right to Buy) | 69107 | $0.00 | 106,387.0000 | 118,678,000 | 39.38% | 0.06% |
| March 8, 2024 | Deschatelets Pascal | Chief Scientific Officer | S | Common Stock | 42750 | $61.88 | 1,142,340.0000 | 118,678,000 | 3.61% | 0.04% |
| March 8, 2024 | Deschatelets Pascal | Chief Scientific Officer | S | Common Stock | 26257 | $62.69 | 1,116,083.0000 | 118,678,000 | 2.30% | 0.02% |
| March 6, 2024 | Watson David O. | General Counsel | M | Common Stock | 3762 | $13.85 | 197,857.0000 | 118,678,000 | 1.94% | 0.00% |
| March 6, 2024 | Watson David O. | General Counsel | M | Stock Option (Right to Buy) | 3762 | $0.00 | 0.0000 | 118,678,000 | 100.00% | 0.00% |
| March 1, 2024 | Francois Cedric | Chief Executive Officer | M | Common Stock | 200000 | $4.31 | 2,285,230.0000 | 118,678,000 | 9.59% | 0.17% |
| March 1, 2024 | Francois Cedric | Chief Executive Officer | S | Common Stock | 28868 | $62.21 | 2,256,362.0000 | 118,678,000 | 1.26% | 0.02% |
| March 1, 2024 | Francois Cedric | Chief Executive Officer | S | Common Stock | 41704 | $62.96 | 2,214,658.0000 | 118,678,000 | 1.85% | 0.04% |
| March 1, 2024 | Francois Cedric | Chief Executive Officer | S | Common Stock | 62503 | $64.26 | 2,152,155.0000 | 118,678,000 | 2.82% | 0.05% |
| March 1, 2024 | Francois Cedric | Chief Executive Officer | S | Common Stock | 116512 | $64.92 | 2,035,643.0000 | 118,678,000 | 5.41% | 0.10% |
| March 1, 2024 | Francois Cedric | Chief Executive Officer | S | Common Stock | 413 | $65.68 | 2,035,230.0000 | 118,678,000 | 0.02% | 0.00% |
| March 1, 2024 | Francois Cedric | Chief Executive Officer | M | Stock Option (Right to Buy) | 50000 | $0.00 | 8,840.0000 | 118,678,000 | 84.98% | 0.04% |
| March 1, 2024 | Francois Cedric | Chief Executive Officer | M | Stock Option (Right to Buy) | 200000 | $0.00 | 175,538.0000 | 118,678,000 | 53.26% | 0.17% |
| March 1, 2024 | Sullivan Timothy Eugene | Chief Financial Officer | M | Common Stock | 6000 | $10.03 | 155,570.0000 | 118,678,000 | 4.01% | 0.01% |
| March 1, 2024 | Sullivan Timothy Eugene | Chief Financial Officer | S | Common Stock | 4000 | $62.86 | 151,570.0000 | 118,678,000 | 2.57% | 0.00% |
| March 1, 2024 | Sullivan Timothy Eugene | Chief Financial Officer | S | Common Stock | 2000 | $63.95 | 149,570.0000 | 118,678,000 | 1.32% | 0.00% |
| March 1, 2024 | Sullivan Timothy Eugene | Chief Financial Officer | M | Stock Option (Right to Buy) | 6000 | $0.00 | 261,903.0000 | 118,678,000 | 2.24% | 0.01% |
| March 1, 2024 | Francois Cedric | Chief Executive Officer | M | Common Stock | 50000 | $3.76 | 2,085,230.0000 | 118,678,000 | 2.46% | 0.04% |
| Feb. 12, 2024 | DeLong Mark Jeffrey | Chief Business & Strat Officer | S | Common Stock | 597 | $67.77 | 64,606.0000 | 118,678,000 | 0.92% | 0.00% |
| Feb. 12, 2024 | Watson David O. | General Counsel | S | Common Stock | 781 | $67.77 | 194,095.0000 | 118,678,000 | 0.40% | 0.00% |
| Feb. 12, 2024 | Townsend Adam J. | Chief Commercial Officer | S | Common Stock | 1148 | $67.77 | 92,453.0000 | 118,678,000 | 1.23% | 0.00% |
| Feb. 12, 2024 | Sullivan Timothy Eugene | Chief Financial Officer | S | Common Stock | 1431 | $67.77 | 149,570.0000 | 118,678,000 | 0.95% | 0.00% |
| Feb. 12, 2024 | Francois Cedric | Chief Executive Officer | S | Common Stock | 3962 | $67.77 | 2,035,230.0000 | 118,678,000 | 0.19% | 0.00% |
| Feb. 12, 2024 | Deschatelets Pascal | Chief Scientific Officer | S | Common Stock | 1148 | $67.77 | 1,115,983.0000 | 118,678,000 | 0.10% | 0.00% |
| Jan. 30, 2024 | Eisele Jeffrey | Chief Development Officer | S | Common Stock | 971 | $65.53 | 57,208.0000 | 118,678,000 | 1.67% | 0.00% |
| Jan. 29, 2024 | Deschatelets Pascal | Chief Scientific Officer | S | Common Stock | 874 | $64.14 | 1,117,131.0000 | 118,678,000 | 0.08% | 0.00% |
| Jan. 29, 2024 | DeLong Mark Jeffrey | Chief Business & Strat Officer | S | Common Stock | 367 | $64.14 | 65,203.0000 | 118,678,000 | 0.56% | 0.00% |
| Jan. 29, 2024 | Watson David O. | General Counsel | S | Common Stock | 906 | $64.14 | 194,876.0000 | 118,678,000 | 0.46% | 0.00% |
| Jan. 29, 2024 | Townsend Adam J. | Chief Commercial Officer | S | Common Stock | 906 | $64.14 | 93,601.0000 | 118,678,000 | 0.96% | 0.00% |
| Jan. 29, 2024 | Sullivan Timothy Eugene | Chief Financial Officer | S | Common Stock | 906 | $64.14 | 151,001.0000 | 118,678,000 | 0.60% | 0.00% |
| Jan. 29, 2024 | Nicholson Nur | Chief Technical Officer | S | Common Stock | 835 | $64.14 | 67,507.0000 | 118,678,000 | 1.22% | 0.00% |
| Jan. 29, 2024 | Lewis Karen | Chief People Officer | S | Common Stock | 367 | $64.14 | 47,270.0000 | 118,678,000 | 0.77% | 0.00% |
| Jan. 30, 2024 | Lewis Karen | Chief People Officer | S | Common Stock | 883 | $65.53 | 46,387.0000 | 118,678,000 | 1.87% | 0.00% |
| Jan. 29, 2024 | Francois Cedric | Chief Executive Officer | S | Common Stock | 2843 | $64.14 | 2,039,192.0000 | 118,678,000 | 0.14% | 0.00% |
| Jan. 29, 2024 | Eisele Jeffrey | Chief Development Officer | S | Common Stock | 279 | $64.14 | 58,179.0000 | 118,678,000 | 0.48% | 0.00% |
| Jan. 23, 2024 | Eisele Jeffrey | Chief Development Officer | S | Common Stock | 7378 | $63.69 | 58,458.0000 | 118,678,000 | 11.21% | 0.01% |
| Jan. 23, 2024 | Lewis Karen | Chief People Officer | S | Common Stock | 4286 | $63.69 | 47,637.0000 | 118,678,000 | 8.25% | 0.00% |
| Jan. 22, 2024 | Townsend Adam J. | Chief Commercial Officer | S | Common Stock | 3413 | $65.00 | 94,507.0000 | 118,678,000 | 3.49% | 0.00% |
| Jan. 22, 2024 | Watson David O. | General Counsel | S | Common Stock | 4184 | $65.00 | 195,782.0000 | 118,678,000 | 2.09% | 0.00% |
| Jan. 22, 2024 | Francois Cedric | Chief Executive Officer | S | Common Stock | 13431 | $65.00 | 2,042,035.0000 | 118,678,000 | 0.65% | 0.01% |
| Jan. 22, 2024 | Nicholson Nur | Chief Technical Officer | S | Common Stock | 2593 | $65.00 | 68,342.0000 | 118,678,000 | 3.66% | 0.00% |
| Jan. 22, 2024 | Sullivan Timothy Eugene | Chief Financial Officer | S | Common Stock | 3551 | $65.00 | 151,907.0000 | 118,678,000 | 2.28% | 0.00% |
| Jan. 22, 2024 | Eisele Jeffrey | Chief Development Officer | S | Common Stock | 1607 | $65.00 | 65,836.0000 | 118,678,000 | 2.38% | 0.00% |
| Jan. 22, 2024 | Lewis Karen | Chief People Officer | S | Common Stock | 1738 | $65.00 | 51,923.0000 | 118,678,000 | 3.24% | 0.00% |
| Jan. 22, 2024 | Chopas James George | VP/Chief Accounting Officer | S | Common Stock | 1061 | $65.00 | 39,067.0000 | 118,678,000 | 2.64% | 0.00% |
| Jan. 22, 2024 | DeLong Mark Jeffrey | Chief Business & Strat Officer | S | Common Stock | 1384 | $65.00 | 65,570.0000 | 118,678,000 | 2.07% | 0.00% |
| Jan. 22, 2024 | Deschatelets Pascal | Chief Scientific Officer | S | Common Stock | 3913 | $65.00 | 1,118,005.0000 | 118,678,000 | 0.35% | 0.00% |
| Jan. 17, 2024 | Lewis Karen | Chief People Officer | S | Common Stock | 3276 | $65.58 | 53,661.0000 | 118,678,000 | 5.75% | 0.00% |
| Jan. 17, 2024 | Eisele Jeffrey | Chief Development Officer | S | Common Stock | 5207 | $65.58 | 67,443.0000 | 118,678,000 | 7.17% | 0.00% |
| Jan. 16, 2024 | Sullivan Timothy Eugene | Chief Financial Officer | A | Common Stock | 23748 | $0.00 | 157,693.0000 | 118,678,000 | 17.73% | 0.02% |
| Jan. 16, 2024 | Townsend Adam J. | Chief Commercial Officer | S | Common Stock | 2235 | $66.81 | 97,920.0000 | 118,678,000 | 2.23% | 0.00% |
| Jan. 16, 2024 | Townsend Adam J. | Chief Commercial Officer | A | Common Stock | 23748 | $0.00 | 100,155.0000 | 118,678,000 | 31.08% | 0.02% |
| Jan. 16, 2024 | Watson David O. | General Counsel | A | Stock Option (Right to Buy) | 34533 | $66.30 | 34,533.0000 | 118,678,000 | 9999.99% | 0.03% |
| Jan. 16, 2024 | Watson David O. | General Counsel | A | Common Stock | 23748 | $0.00 | 204,206.0000 | 118,678,000 | 13.16% | 0.02% |
| Jan. 16, 2024 | Watson David O. | General Counsel | S | Common Stock | 4240 | $66.81 | 199,966.0000 | 118,678,000 | 2.08% | 0.00% |
| Jan. 16, 2024 | Eisele Jeffrey | Chief Development Officer | A | Stock Option (Right to Buy) | 28367 | $66.30 | 28,367.0000 | 118,678,000 | 9999.99% | 0.02% |
| Jan. 16, 2024 | Eisele Jeffrey | Chief Development Officer | S | Common Stock | 438 | $66.81 | 72,650.0000 | 118,678,000 | 0.60% | 0.00% |
| Jan. 16, 2024 | Eisele Jeffrey | Chief Development Officer | A | Common Stock | 19508 | $0.00 | 73,088.0000 | 118,678,000 | 36.41% | 0.02% |
| Jan. 16, 2024 | Francois Cedric | Chief Executive Officer | A | Stock Option (Right to Buy) | 104834 | $66.30 | 104,834.0000 | 118,678,000 | 9999.99% | 0.09% |
| Jan. 16, 2024 | Francois Cedric | Chief Executive Officer | S | Common Stock | 7851 | $66.81 | 2,055,466.0000 | 118,678,000 | 0.38% | 0.01% |
| Jan. 16, 2024 | Francois Cedric | Chief Executive Officer | A | Common Stock | 72094 | $0.00 | 2,063,317.0000 | 118,678,000 | 3.62% | 0.06% |
| Jan. 16, 2024 | Baumal Caroline | Chief Medical Officer | A | Stock Option (Right to Buy) | 37000 | $66.30 | 37,000.0000 | 118,678,000 | 9999.99% | 0.03% |
| Jan. 16, 2024 | Baumal Caroline | Chief Medical Officer | A | Common Stock | 25445 | $0.00 | 58,376.3700 | 118,678,000 | 77.27% | 0.02% |
| Jan. 16, 2024 | Sullivan Timothy Eugene | Chief Financial Officer | A | Stock Option (Right to Buy) | 34533 | $66.30 | 34,533.0000 | 118,678,000 | 9999.99% | 0.03% |
| Jan. 16, 2024 | Sullivan Timothy Eugene | Chief Financial Officer | S | Common Stock | 2235 | $66.81 | 155,458.0000 | 118,678,000 | 1.42% | 0.00% |
| Jan. 16, 2024 | Townsend Adam J. | Chief Commercial Officer | A | Stock Option (Right to Buy) | 34533 | $66.30 | 34,533.0000 | 118,678,000 | 9999.99% | 0.03% |
| Jan. 16, 2024 | Deschatelets Pascal | Chief Scientific Officer | A | Common Stock | 6743 | $0.00 | 1,123,550.0000 | 118,678,000 | 0.60% | 0.01% |
| Jan. 16, 2024 | Deschatelets Pascal | Chief Scientific Officer | S | Common Stock | 1632 | $66.81 | 1,121,918.0000 | 118,678,000 | 0.15% | 0.00% |
| Jan. 16, 2024 | Deschatelets Pascal | Chief Scientific Officer | A | Stock Option (Right to Buy) | 9805 | $66.30 | 9,805.0000 | 118,678,000 | 9999.99% | 0.01% |
| Jan. 16, 2024 | Chopas James George | VP/Chief Accounting Officer | A | Common Stock | 8312 | $0.00 | 40,992.0000 | 118,678,000 | 25.43% | 0.01% |
| Jan. 16, 2024 | Chopas James George | VP/Chief Accounting Officer | S | Common Stock | 864 | $66.81 | 40,128.0000 | 118,678,000 | 2.11% | 0.00% |
| Jan. 16, 2024 | Chopas James George | VP/Chief Accounting Officer | A | Stock Option (Right to Buy) | 12086 | $66.30 | 12,086.0000 | 118,678,000 | 9999.99% | 0.01% |
| Jan. 16, 2024 | Lewis Karen | Chief People Officer | A | Common Stock | 16963 | $0.00 | 58,569.0000 | 118,678,000 | 40.77% | 0.01% |
| Jan. 16, 2024 | Lewis Karen | Chief People Officer | S | Common Stock | 1632 | $66.81 | 56,937.0000 | 118,678,000 | 2.79% | 0.00% |
| Jan. 16, 2024 | Lewis Karen | Chief People Officer | A | Stock Option (Right to Buy) | 24666 | $66.30 | 24,666.0000 | 118,678,000 | 9999.99% | 0.02% |
| Jan. 16, 2024 | DeLong Mark Jeffrey | Chief Business & Strat Officer | A | Common Stock | 16963 | $0.00 | 68,585.0000 | 118,678,000 | 32.86% | 0.01% |
| Jan. 16, 2024 | DeLong Mark Jeffrey | Chief Business & Strat Officer | S | Common Stock | 1631 | $66.81 | 66,954.0000 | 118,678,000 | 2.38% | 0.00% |
| Jan. 16, 2024 | DeLong Mark Jeffrey | Chief Business & Strat Officer | A | Stock Option (Right to Buy) | 24666 | $66.30 | 24,666.0000 | 118,678,000 | 9999.99% | 0.02% |
| Jan. 16, 2024 | Nicholson Nur | Chief Technical Officer | A | Common Stock | 19508 | $0.00 | 72,792.0000 | 118,678,000 | 36.61% | 0.02% |
| Jan. 16, 2024 | Nicholson Nur | Chief Technical Officer | S | Common Stock | 1857 | $66.81 | 70,935.0000 | 118,678,000 | 2.55% | 0.00% |
| Jan. 16, 2024 | Nicholson Nur | Chief Technical Officer | A | Stock Option (Right to Buy) | 28367 | $66.30 | 28,367.0000 | 118,678,000 | 9999.99% | 0.02% |
| Jan. 4, 2024 | Baumal Caroline | Chief Medical Officer | S | Common Stock | 2751 | $60.05 | 32,931.3700 | 118,678,000 | 7.71% | 0.00% |
| Jan. 1, 2024 | Dunlop A. Sinclair | Director | A | Stock Option (Right to Buy) | 5748 | $59.86 | 5,748.0000 | 118,678,000 | 9999.99% | 0.00% |
| Jan. 1, 2024 | Machiels Alec | Director | A | Stock Option (Right to Buy) | 5748 | $59.86 | 5,748.0000 | 118,678,000 | 9999.99% | 0.00% |
| Jan. 1, 2024 | Machiels Alec | Director | A | Common Stock | 3341 | $0.00 | 782,711.0000 | 118,678,000 | 0.43% | 0.00% |
| Jan. 1, 2024 | Chan Gerald | Director | A | Stock Option (Right to Buy) | 5748 | $59.86 | 5,748.0000 | 118,678,000 | 9999.99% | 0.00% |
| Jan. 1, 2024 | Chan Gerald | Director | A | Common Stock | 3341 | $0.00 | 11,438.0000 | 118,678,000 | 41.26% | 0.00% |
| Jan. 1, 2024 | Dunlop A. Sinclair | Director | A | Common Stock | 3341 | $0.00 | 356,552.0000 | 118,678,000 | 0.95% | 0.00% |
| Jan. 1, 2024 | FONTEYNE PAUL R. | Director | A | Common Stock | 3341 | $0.00 | 16,438.0000 | 118,678,000 | 25.51% | 0.00% |
| Jan. 1, 2024 | FONTEYNE PAUL R. | Director | A | Stock Option (Right to Buy) | 5748 | $59.86 | 5,748.0000 | 118,678,000 | 9999.99% | 0.00% |
| Jan. 1, 2024 | O'Brien Stephanie Monaghan | Director | A | Common Stock | 3341 | $0.00 | 11,438.0000 | 118,678,000 | 41.26% | 0.00% |
| Jan. 1, 2024 | O'Brien Stephanie Monaghan | Director | A | Stock Option (Right to Buy) | 5748 | $59.86 | 5,748.0000 | 118,678,000 | 9999.99% | 0.00% |
| Dec. 26, 2023 | Eisele Jeffrey | Chief Development Officer | S | Common Stock | 68 | $57.86 | 53,815.0000 | 106,114,000 | 0.13% | 0.00% |
| Dec. 27, 2023 | Eisele Jeffrey | Chief Development Officer | S | Common Stock | 235 | $60.23 | 53,580.0000 | 106,114,000 | 0.44% | 0.00% |
| Dec. 19, 2023 | Watson David O. | General Counsel | S | Common Stock | 1605 | $57.00 | 182,758.0000 | 106,114,000 | 0.87% | 0.00% |
| Dec. 19, 2023 | Watson David O. | General Counsel | M | Common Stock | 7905 | $13.85 | 184,363.0000 | 106,114,000 | 4.48% | 0.01% |
| Dec. 19, 2023 | Watson David O. | General Counsel | S | Common Stock | 2300 | $57.38 | 180,458.0000 | 106,114,000 | 1.26% | 0.00% |
| Dec. 19, 2023 | Watson David O. | General Counsel | M | Stock Option (Right to Buy) | 7905 | $0.00 | 3,762.0000 | 106,114,000 | 67.76% | 0.01% |
| Dec. 14, 2023 | Dunlop A. Sinclair | Director | M | Stock Option (Right to Buy) | 6274 | $0.00 | 7,000.0000 | 106,114,000 | 47.27% | 0.01% |
| Dec. 14, 2023 | Dunlop A. Sinclair | Director | M | Common Stock | 6274 | $13.19 | 353,211.0000 | 106,114,000 | 1.81% | 0.01% |
| Dec. 1, 2023 | SCHEIBLER LUKAS | Chief Research Officer | S | Common Stock | 10000 | $60.00 | 68,299.0000 | 106,114,000 | 12.77% | 0.01% |
| Dec. 1, 2023 | SCHEIBLER LUKAS | Chief Research Officer | M | Stock Option (Right to Buy) | 10000 | $0.00 | 39,391.0000 | 106,114,000 | 20.25% | 0.01% |
| Dec. 1, 2023 | Townsend Adam J. | Chief Commercial Officer | M | Common Stock | 110000 | $15.09 | 186,407.0000 | 106,114,000 | 143.97% | 0.10% |
| Dec. 1, 2023 | Townsend Adam J. | Chief Commercial Officer | S | Common Stock | 67557 | $60.50 | 118,850.0000 | 106,114,000 | 36.24% | 0.06% |
| Dec. 1, 2023 | Townsend Adam J. | Chief Commercial Officer | S | Common Stock | 42443 | $61.31 | 76,407.0000 | 106,114,000 | 35.71% | 0.04% |
| Dec. 1, 2023 | Townsend Adam J. | Chief Commercial Officer | M | Stock Option (Right to Buy) | 110000 | $0.00 | 172,500.0000 | 106,114,000 | 38.94% | 0.10% |
| Dec. 1, 2023 | Dunlop A. Sinclair | Not found | S | Common Stock | 24000 | $61.14 | 346,937.0000 | 106,114,000 | 6.47% | 0.02% |
| Dec. 1, 2023 | SCHEIBLER LUKAS | Chief Research Officer | M | Common Stock | 10000 | $13.85 | 78,299.0000 | 106,114,000 | 14.64% | 0.01% |
| Nov. 30, 2023 | Sullivan Timothy Eugene | Chief Financial Officer | S | Common Stock | 300 | $54.79 | 133,945.0000 | 106,114,000 | 0.22% | 0.00% |
| Nov. 30, 2023 | Sullivan Timothy Eugene | Chief Financial Officer | M | Common Stock | 14158 | $10.03 | 148,103.0000 | 106,114,000 | 10.57% | 0.01% |
| Nov. 30, 2023 | Sullivan Timothy Eugene | Chief Financial Officer | S | Common Stock | 13858 | $54.73 | 134,245.0000 | 106,114,000 | 9.36% | 0.01% |
| Nov. 30, 2023 | Sullivan Timothy Eugene | Chief Financial Officer | M | Stock Option (Right to Buy) | 14158 | $0.00 | 267,903.0000 | 106,114,000 | 5.02% | 0.01% |
| Nov. 17, 2023 | Dunlop A. Sinclair | Director | S | Common Stock | 8894 | $49.99 | 370,937.0000 | 106,114,000 | 2.34% | 0.01% |
| Nov. 21, 2023 | Francois Cedric | Chief Executive Officer | S | Common Stock | 5000 | $48.80 | 1,991,223.0000 | 106,114,000 | 0.25% | 0.00% |
| Oct. 17, 2023 | Dunlop A. Sinclair | Director | S | Common Stock | 24000 | $49.00 | 379,831.0000 | 106,114,000 | 5.94% | 0.02% |
| Nov. 17, 2023 | Machiels Alec | Director | S | Common Stock | 1250 | $47.74 | 779,370.0000 | 106,114,000 | 0.16% | 0.00% |
| Nov. 17, 2023 | Machiels Alec | Director | M | Common Stock | 1250 | $2.67 | 780,620.0000 | 106,114,000 | 0.16% | 0.00% |
| Nov. 17, 2023 | Machiels Alec | Director | M | Stock Option (Right to Buy) | 1250 | $0.00 | 0.0000 | 106,114,000 | 100.00% | 0.00% |
| Nov. 14, 2023 | Deschatelets Pascal | Chief Scientific Officer | M | Common Stock | 45000 | $3.76 | 1,116,807.0000 | 106,114,000 | 4.20% | 0.04% |
| Nov. 14, 2023 | Deschatelets Pascal | Chief Scientific Officer | M | Stock Option (Right to Buy) | 45000 | $0.00 | 175,494.0000 | 106,114,000 | 20.41% | 0.04% |
| Nov. 8, 2023 | Deschatelets Pascal | Chief Scientific Officer | M | Common Stock | 17494 | $2.67 | 1,083,807.0000 | 106,114,000 | 1.64% | 0.02% |
| Nov. 8, 2023 | Deschatelets Pascal | Chief Scientific Officer | S | Common Stock | 12000 | $47.27 | 1,071,807.0000 | 106,114,000 | 1.11% | 0.01% |
| Nov. 8, 2023 | Deschatelets Pascal | Chief Scientific Officer | M | Stock Option (Right to Buy) | 17494 | $0.00 | 0.0000 | 106,114,000 | 100.00% | 0.02% |
| Oct. 23, 2023 | DeLong Mark Jeffrey | Chief Business & Strat Officer | S | Common Stock | 131 | $46.04 | 51,622.0000 | 106,114,000 | 0.25% | 0.00% |
| Oct. 23, 2023 | Chopas James George | VP/Chief Accounting Officer | S | Common Stock | 132 | $46.04 | 32,680.0000 | 106,114,000 | 0.40% | 0.00% |
| Oct. 17, 2023 | Machiels Alec | Director | S | Common Stock | 1250 | $48.50 | 779,370.0000 | 106,114,000 | 0.16% | 0.00% |
| Oct. 17, 2023 | Machiels Alec | Director | M | Common Stock | 1250 | $2.67 | 780,620.0000 | 106,114,000 | 0.16% | 0.00% |
| Oct. 17, 2023 | Machiels Alec | Director | M | Stock Option (Right to Buy) | 1250 | $0.00 | 1,250.0000 | 106,114,000 | 50.00% | 0.00% |
| Oct. 9, 2023 | Deschatelets Pascal | Chief Scientific Officer | S | Common Stock | 12000 | $40.38 | 1,066,313.0000 | 106,114,000 | 1.11% | 0.01% |
| Oct. 9, 2023 | Deschatelets Pascal | Chief Scientific Officer | M | Common Stock | 18500 | $2.67 | 1,078,313.0000 | 106,114,000 | 1.75% | 0.02% |
| Oct. 9, 2023 | Deschatelets Pascal | Chief Scientific Officer | M | Stock Option (Right to Buy) | 18500 | $0.00 | 17,494.0000 | 106,114,000 | 51.40% | 0.02% |
| Sept. 19, 2023 | Francois Cedric | Chief Executive Officer | G | Common Stock | 150000 | $0.00 | 1,996,223.0000 | 106,114,000 | 6.99% | 0.14% |
| Sept. 19, 2023 | Francois Cedric | Chief Executive Officer | G | Common Stock | 150000 | $0.00 | 1,996,223.0000 | 106,114,000 | 8.12% | 0.14% |
| Sept. 18, 2023 | Nicholson Nur | Chief Technical Officer | S | Common Stock | 10631 | $46.15 | 53,284.0000 | 106,114,000 | 16.63% | 0.01% |
| Sept. 18, 2023 | Machiels Alec | Director | M | Common Stock | 1250 | $2.67 | 780,620.0000 | 106,114,000 | 0.16% | 0.00% |
| Sept. 18, 2023 | Machiels Alec | Director | S | Common Stock | 1250 | $45.00 | 779,370.0000 | 106,114,000 | 0.16% | 0.00% |
| Sept. 18, 2023 | Machiels Alec | Director | M | Stock Option (Right to Buy) | 1250 | $0.00 | 2,500.0000 | 106,114,000 | 33.33% | 0.00% |
| Sept. 18, 2023 | Nicholson Nur | Chief Technical Officer | M | Common Stock | 9719 | $29.76 | 73,634.0000 | 106,114,000 | 15.21% | 0.01% |
| Sept. 18, 2023 | Nicholson Nur | Chief Technical Officer | S | Common Stock | 9719 | $42.21 | 63,915.0000 | 106,114,000 | 13.20% | 0.01% |
| Sept. 18, 2023 | Nicholson Nur | Chief Technical Officer | M | Stock Option (Right to Buy) | 9719 | $0.00 | 115,281.0000 | 106,114,000 | 7.78% | 0.01% |
| Sept. 15, 2023 | Machiels Alec | Director | M | Stock Option (Right to Buy) | 1250 | $0.00 | 3,750.0000 | 106,114,000 | 25.00% | 0.00% |
| Sept. 15, 2023 | Machiels Alec | Director | M | Common Stock | 1250 | $2.67 | 780,620.0000 | 106,114,000 | 0.16% | 0.00% |
| Sept. 15, 2023 | Machiels Alec | Director | S | Common Stock | 1250 | $45.34 | 779,370.0000 | 106,114,000 | 0.16% | 0.00% |
| Sept. 14, 2023 | Chopas James George | VP/Chief Accounting Officer | A | Common Stock | 2500 | $0.00 | 32,812.0000 | 106,114,000 | 8.25% | 0.00% |
| Sept. 8, 2023 | Deschatelets Pascal | Chief Scientific Officer | M | Common Stock | 18500 | $2.67 | 1,071,813.0000 | 106,114,000 | 1.76% | 0.02% |
| Sept. 8, 2023 | Deschatelets Pascal | Chief Scientific Officer | M | Stock Option (Right to Buy) | 18500 | $0.00 | 35,994.0000 | 106,114,000 | 33.95% | 0.02% |
| Sept. 8, 2023 | Deschatelets Pascal | Chief Scientific Officer | S | Common Stock | 12000 | $42.87 | 1,059,813.0000 | 106,114,000 | 1.12% | 0.01% |
| Sept. 6, 2023 | SCHEIBLER LUKAS | Chief Research Officer | S | Common Stock | 1756 | $43.01 | 68,299.0000 | 106,114,000 | 2.51% | 0.00% |
| Aug. 31, 2023 | Chopas James George | VP/Chief Accounting Officer | S | Common Stock | 551 | $41.23 | 30,312.0000 | 106,114,000 | 1.79% | 0.00% |
| Sept. 1, 2023 | Francois Cedric | Chief Executive Officer | M | Stock Option (Right to Buy) | 300000 | $0.00 | 0.0000 | 106,114,000 | 100.00% | 0.28% |
| Sept. 1, 2023 | Francois Cedric | Chief Executive Officer | S | Common Stock | 10284 | $42.44 | 1,996,223.0000 | 106,114,000 | 0.51% | 0.01% |
| Sept. 1, 2023 | Francois Cedric | Chief Executive Officer | S | Common Stock | 139716 | $41.70 | 2,006,507.0000 | 106,114,000 | 6.51% | 0.13% |
| Sept. 1, 2023 | Francois Cedric | Chief Executive Officer | M | Common Stock | 300000 | $2.67 | 2,146,223.0000 | 106,114,000 | 16.25% | 0.28% |
| Aug. 8, 2023 | Deschatelets Pascal | Chief Scientific Officer | M | Stock Option (Right to Buy) | 18500 | $0.00 | 54,494.0000 | 106,114,000 | 25.34% | 0.02% |
| Aug. 8, 2023 | Deschatelets Pascal | Chief Scientific Officer | S | Common Stock | 12000 | $23.66 | 1,053,313.0000 | 106,114,000 | 1.13% | 0.01% |
| Aug. 8, 2023 | Deschatelets Pascal | Chief Scientific Officer | M | Common Stock | 18500 | $2.67 | 1,065,313.0000 | 106,114,000 | 1.77% | 0.02% |
| July 21, 2023 | Machiels Alec | Director | M | Common Stock | 49779 | $2.67 | 779,370.0000 | 106,114,000 | 6.82% | 0.05% |
| July 21, 2023 | Machiels Alec | Director | M | Stock Option (Right to Buy) | 49779 | $0.00 | 5,000.0000 | 106,114,000 | 90.87% | 0.05% |
| July 20, 2023 | Machiels Alec | Director | M | Common Stock | 50000 | $2.67 | 729,591.0000 | 106,114,000 | 7.36% | 0.05% |
| July 20, 2023 | Machiels Alec | Director | M | Stock Option (Right to Buy) | 50000 | $0.00 | 54,779.0000 | 106,114,000 | 47.72% | 0.05% |
| July 17, 2023 | Machiels Alec | Director | M | Stock Option (Right to Buy) | 1250 | $0.00 | 104,779.0000 | 106,114,000 | 1.18% | 0.00% |
| July 17, 2023 | Machiels Alec | Director | S | Common Stock | 1250 | $64.79 | 679,591.0000 | 106,114,000 | 0.18% | 0.00% |
| July 17, 2023 | Machiels Alec | Director | M | Common Stock | 1250 | $2.67 | 680,841.0000 | 106,114,000 | 0.18% | 0.00% |
| July 10, 2023 | Deschatelets Pascal | Chief Scientific Officer | S | Common Stock | 12000 | $84.55 | 1,046,813.0000 | 106,114,000 | 1.13% | 0.01% |
| July 10, 2023 | Deschatelets Pascal | Chief Scientific Officer | M | Stock Option (Right to Buy) | 18500 | $0.00 | 72,994.0000 | 106,114,000 | 20.22% | 0.02% |
| July 10, 2023 | Deschatelets Pascal | Chief Scientific Officer | M | Common Stock | 18500 | $2.67 | 1,058,813.0000 | 106,114,000 | 1.78% | 0.02% |
| July 3, 2023 | Sullivan Timothy Eugene | Chief Financial Officer | S | Common Stock | 3287 | $90.42 | 134,245.0000 | 106,114,000 | 2.39% | 0.00% |
| July 3, 2023 | Sullivan Timothy Eugene | Chief Financial Officer | M | Common Stock | 6779 | $10.03 | 140,724.0000 | 106,114,000 | 5.06% | 0.01% |
| July 3, 2023 | Watson David O. | General Counsel | S | Common Stock | 8510 | $89.98 | 176,458.0000 | 106,114,000 | 4.60% | 0.01% |
| July 3, 2023 | Sullivan Timothy Eugene | Chief Financial Officer | S | Common Stock | 300 | $91.10 | 133,945.0000 | 106,114,000 | 0.22% | 0.00% |
| July 3, 2023 | Sullivan Timothy Eugene | Chief Financial Officer | S | Common Stock | 3192 | $89.41 | 137,532.0000 | 106,114,000 | 2.27% | 0.00% |
| July 3, 2023 | Sullivan Timothy Eugene | Chief Financial Officer | M | Stock Option (Right to Buy) | 6779 | $0.00 | 282,061.0000 | 106,114,000 | 2.35% | 0.01% |
| June 28, 2023 | Watson David O. | General Counsel | G | Common Stock | 12750 | $0.00 | 184,968.0000 | 106,114,000 | 7.40% | 0.01% |
| June 28, 2023 | Watson David O. | General Counsel | G | Common Stock | 12750 | $0.00 | 184,968.0000 | 106,114,000 | 6.45% | 0.01% |
| June 20, 2023 | Machiels Alec | Director | S | Common Stock | 1250 | $88.41 | 679,591.0000 | 106,114,000 | 0.18% | 0.00% |
| June 20, 2023 | Machiels Alec | Director | M | Stock Option (Right to Buy) | 1250 | $0.00 | 106,029.0000 | 106,114,000 | 1.17% | 0.00% |
| June 20, 2023 | Machiels Alec | Director | M | Common Stock | 1250 | $2.67 | 680,841.0000 | 106,114,000 | 0.18% | 0.00% |
| June 8, 2023 | Deschatelets Pascal | Chief Scientific Officer | M | Common Stock | 18500 | $2.67 | 1,052,313.0000 | 106,114,000 | 1.79% | 0.02% |
| June 8, 2023 | Deschatelets Pascal | Chief Scientific Officer | S | Common Stock | 12000 | $91.35 | 1,040,313.0000 | 106,114,000 | 1.14% | 0.01% |
| June 8, 2023 | Deschatelets Pascal | Chief Scientific Officer | M | Stock Option (Right to Buy) | 18500 | $0.00 | 91,494.0000 | 106,114,000 | 16.82% | 0.02% |
| June 5, 2023 | Sullivan Timothy Eugene | Chief Financial Officer | S | Common Stock | 1600 | $90.60 | 202,124.0000 | 106,114,000 | 0.79% | 0.00% |
| June 5, 2023 | Sullivan Timothy Eugene | Chief Financial Officer | M | Common Stock | 69779 | $10.03 | 203,724.0000 | 106,114,000 | 52.10% | 0.07% |
| June 5, 2023 | Sullivan Timothy Eugene | Chief Financial Officer | S | Common Stock | 30609 | $87.79 | 171,515.0000 | 106,114,000 | 15.14% | 0.03% |
| June 5, 2023 | Sullivan Timothy Eugene | Chief Financial Officer | M | Stock Option (Right to Buy) | 69779 | $0.00 | 288,840.0000 | 106,114,000 | 19.46% | 0.07% |
| June 5, 2023 | Sullivan Timothy Eugene | Chief Financial Officer | S | Common Stock | 30506 | $89.83 | 133,945.0000 | 106,114,000 | 18.55% | 0.03% |
| June 5, 2023 | Sullivan Timothy Eugene | Chief Financial Officer | S | Common Stock | 7064 | $88.36 | 164,451.0000 | 106,114,000 | 4.12% | 0.01% |
| June 1, 2023 | Lewis Karen | Chief People Officer | S | Common Stock | 5000 | $86.00 | 41,504.0000 | 106,114,000 | 10.75% | 0.00% |
| June 1, 2023 | Lewis Karen | Chief People Officer | M | Common Stock | 5000 | $34.11 | 46,504.0000 | 106,114,000 | 12.05% | 0.00% |
| June 1, 2023 | Lewis Karen | Chief People Officer | M | Stock Option (Right to Buy) | 5000 | $0.00 | 106,000.0000 | 106,114,000 | 4.50% | 0.00% |
| May 24, 2023 | Francois Cedric | Chief Executive Officer | G | Common Stock | 20000 | $0.00 | 1,846,223.0000 | 106,114,000 | 1.07% | 0.02% |
| May 24, 2023 | Francois Cedric | Chief Executive Officer | G | Common Stock | 20000 | $0.00 | 1,846,223.0000 | 106,114,000 | 1.10% | 0.02% |
| May 16, 2023 | Francois Cedric | Chief Executive Officer | S | Common Stock | 2120 | $87.67 | 1,826,223.0000 | 106,114,000 | 0.12% | 0.00% |
| May 17, 2023 | Francois Cedric | Chief Executive Officer | M | Common Stock | 20000 | $2.67 | 1,846,223.0000 | 106,114,000 | 1.10% | 0.02% |
| May 17, 2023 | Francois Cedric | Chief Executive Officer | M | Stock Option (Right to Buy) | 20000 | $0.00 | 300,000.0000 | 106,114,000 | 6.25% | 0.02% |
| May 16, 2023 | Francois Cedric | Chief Executive Officer | M | Stock Option (Right to Buy) | 30000 | $0.00 | 320,000.0000 | 106,114,000 | 8.57% | 0.03% |
| May 16, 2023 | Francois Cedric | Chief Executive Officer | S | Common Stock | 14611 | $85.01 | 1,838,878.0000 | 106,114,000 | 0.79% | 0.01% |
| May 16, 2023 | Francois Cedric | Chief Executive Officer | S | Common Stock | 3007 | $85.90 | 1,835,871.0000 | 106,114,000 | 0.16% | 0.00% |
| May 16, 2023 | Francois Cedric | Chief Executive Officer | S | Common Stock | 7528 | $87.02 | 1,828,343.0000 | 106,114,000 | 0.41% | 0.01% |
| May 17, 2023 | Machiels Alec | Director | M | Common Stock | 1250 | $2.67 | 680,841.0000 | 106,114,000 | 0.18% | 0.00% |
| May 17, 2023 | Machiels Alec | Director | S | Common Stock | 1250 | $88.66 | 679,591.0000 | 106,114,000 | 0.18% | 0.00% |
| May 17, 2023 | Machiels Alec | Director | M | Stock Option (Right to Buy) | 1250 | $0.00 | 107,279.0000 | 106,114,000 | 1.15% | 0.00% |
| May 16, 2023 | Francois Cedric | Chief Executive Officer | M | Common Stock | 30000 | $2.67 | 1,856,223.0000 | 106,114,000 | 1.64% | 0.03% |
| May 16, 2023 | Francois Cedric | Chief Executive Officer | S | Common Stock | 934 | $83.17 | 1,855,289.0000 | 106,114,000 | 0.05% | 0.00% |
| May 16, 2023 | Francois Cedric | Chief Executive Officer | S | Common Stock | 1800 | $83.85 | 1,853,489.0000 | 106,114,000 | 0.10% | 0.00% |
| May 8, 2023 | Deschatelets Pascal | Chief Scientific Officer | M | Common Stock | 18500 | $2.67 | 1,045,813.0000 | 106,114,000 | 1.80% | 0.02% |
| May 8, 2023 | Deschatelets Pascal | Chief Scientific Officer | S | Common Stock | 12000 | $92.39 | 1,033,813.0000 | 106,114,000 | 1.15% | 0.01% |
| May 8, 2023 | Deschatelets Pascal | Chief Scientific Officer | M | Stock Option (Right to Buy) | 18500 | $0.00 | 109,994.0000 | 106,114,000 | 14.40% | 0.02% |
| May 3, 2023 | Townsend Adam J. | Chief Commercial Officer | M | Stock Option (Right to Buy) | 5000 | $0.00 | 282,500.0000 | 106,114,000 | 1.74% | 0.00% |
| May 3, 2023 | Townsend Adam J. | Chief Commercial Officer | M | Common Stock | 5000 | $15.09 | 80,995.0000 | 106,114,000 | 6.58% | 0.00% |
| May 3, 2023 | Townsend Adam J. | Chief Commercial Officer | S | Common Stock | 5000 | $82.71 | 75,995.0000 | 106,114,000 | 6.17% | 0.00% |
| May 3, 2023 | Sullivan Timothy Eugene | Chief Financial Officer | G | Common Stock | 20000 | $0.00 | 133,945.0000 | 106,114,000 | 12.99% | 0.02% |
| May 3, 2023 | Sullivan Timothy Eugene | Chief Financial Officer | G | Common Stock | 20000 | $0.00 | 133,945.0000 | 106,114,000 | 17.55% | 0.02% |
| April 27, 2023 | Francois Cedric | Chief Executive Officer | G | Common Stock | 382946 | $0.00 | 1,826,223.0000 | 106,114,000 | 17.33% | 0.36% |
| April 27, 2023 | Francois Cedric | Chief Executive Officer | G | Common Stock | 382946 | $0.00 | 1,826,223.0000 | 106,114,000 | 26.53% | 0.36% |
| April 21, 2023 | Watson David O. | General Counsel | G | Common Stock | 67955 | $0.00 | 184,968.0000 | 106,114,000 | 58.07% | 0.06% |
| April 21, 2023 | Watson David O. | General Counsel | G | Common Stock | 67955 | $0.00 | 184,968.0000 | 106,114,000 | 26.87% | 0.06% |
| April 19, 2023 | Sullivan Timothy Eugene | Chief Financial Officer | G | Common Stock | 36232 | $0.00 | 133,945.0000 | 106,114,000 | 37.08% | 0.03% |
| April 18, 2023 | Francois Cedric | Chief Executive Officer | M | Common Stock | 30000 | $2.67 | 1,836,223.0000 | 106,114,000 | 1.66% | 0.03% |
| April 18, 2023 | Francois Cedric | Chief Executive Officer | S | Common Stock | 30000 | $82.02 | 1,806,223.0000 | 106,114,000 | 1.63% | 0.03% |
| April 19, 2023 | Francois Cedric | Chief Executive Officer | M | Common Stock | 20000 | $2.67 | 1,826,223.0000 | 106,114,000 | 1.11% | 0.02% |
| April 18, 2023 | Francois Cedric | Chief Executive Officer | M | Stock Option (Right to Buy) | 30000 | $0.00 | 370,000.0000 | 106,114,000 | 7.50% | 0.03% |
| April 19, 2023 | Francois Cedric | Chief Executive Officer | M | Stock Option (Right to Buy) | 20000 | $0.00 | 350,000.0000 | 106,114,000 | 5.41% | 0.02% |
| April 19, 2023 | Sullivan Timothy Eugene | Chief Financial Officer | G | Common Stock | 36232 | $0.00 | 133,945.0000 | 106,114,000 | 21.29% | 0.03% |
| April 17, 2023 | Machiels Alec | Director | M | Stock Option (Right to Buy) | 1250 | $0.00 | 108,529.0000 | 106,114,000 | 1.14% | 0.00% |
| April 17, 2023 | Machiels Alec | Director | S | Common Stock | 1250 | $81.05 | 679,591.0000 | 106,114,000 | 0.18% | 0.00% |
| April 17, 2023 | Machiels Alec | Director | M | Common Stock | 1250 | $2.67 | 680,841.0000 | 106,114,000 | 0.18% | 0.00% |
| April 10, 2023 | Deschatelets Pascal | Chief Scientific Officer | M | Stock Option (Right to Buy) | 18500 | $0.00 | 128,494.0000 | 106,114,000 | 12.59% | 0.02% |
| April 10, 2023 | Deschatelets Pascal | Chief Scientific Officer | S | Common Stock | 12000 | $78.21 | 1,027,313.0000 | 106,114,000 | 1.15% | 0.01% |
| April 10, 2023 | Deschatelets Pascal | Chief Scientific Officer | M | Common Stock | 18500 | $2.67 | 1,039,313.0000 | 106,114,000 | 1.81% | 0.02% |
| April 3, 2023 | Francois Cedric | Chief Executive Officer | G | Common Stock | 227221 | $0.00 | 1,399,233.0000 | 106,114,000 | 19.39% | 0.21% |
| April 3, 2023 | Francois Cedric | Chief Executive Officer | G | Common Stock | 227221 | $0.00 | 2,213,213.0000 | 106,114,000 | 9.31% | 0.21% |
| April 4, 2023 | Francois Cedric | Chief Executive Officer | G | Common Stock | 380000 | $0.00 | 1,833,213.0000 | 106,114,000 | 17.17% | 0.36% |
| April 5, 2023 | Francois Cedric | Chief Executive Officer | G | Common Stock | 26990 | $0.00 | 1,806,223.0000 | 106,114,000 | 1.47% | 0.03% |
| April 4, 2023 | Francois Cedric | Chief Executive Officer | G | Common Stock | 380000 | $0.00 | 1,779,233.0000 | 106,114,000 | 27.16% | 0.36% |
| April 5, 2023 | Francois Cedric | Chief Executive Officer | G | Common Stock | 26990 | $0.00 | 1,806,223.0000 | 106,114,000 | 1.52% | 0.03% |
| April 3, 2023 | Dunlop A. Sinclair | Director | S | Common Stock | 500 | $74.05 | 403,831.0000 | 106,114,000 | 0.12% | 0.00% |
| April 3, 2023 | Lewis Karen | Chief People Officer | M | Common Stock | 5000 | $34.11 | 46,430.0000 | 106,114,000 | 12.07% | 0.00% |
| April 3, 2023 | Lewis Karen | Chief People Officer | S | Common Stock | 5000 | $75.00 | 41,430.0000 | 106,114,000 | 10.77% | 0.00% |
| April 3, 2023 | Lewis Karen | Chief People Officer | M | Stock Option (Right to Buy) | 5000 | $0.00 | 111,000.0000 | 106,114,000 | 4.31% | 0.00% |
| April 3, 2023 | Townsend Adam J. | Chief Commercial Officer | M | Common Stock | 5000 | $15.09 | 80,995.0000 | 106,114,000 | 6.58% | 0.00% |
| April 3, 2023 | Townsend Adam J. | Chief Commercial Officer | S | Common Stock | 5000 | $74.05 | 75,995.0000 | 106,114,000 | 6.17% | 0.00% |
| April 3, 2023 | Townsend Adam J. | Chief Commercial Officer | M | Stock Option (Right to Buy) | 5000 | $0.00 | 287,500.0000 | 106,114,000 | 1.71% | 0.00% |
| March 22, 2023 | Francois Cedric | Chief Executive Officer | M | Stock Option (Right to Buy) | 7221 | $0.00 | 273,779.0000 | 106,114,000 | 2.57% | 0.01% |
| March 22, 2023 | Francois Cedric | Chief Executive Officer | M | Stock Option (Right to Buy) | 100000 | $0.00 | 58,840.0000 | 106,114,000 | 62.96% | 0.09% |
| March 22, 2023 | Francois Cedric | Chief Executive Officer | M | Stock Option (Right to Buy) | 20000 | $0.00 | 400,000.0000 | 106,114,000 | 4.76% | 0.02% |
| March 21, 2023 | Francois Cedric | Chief Executive Officer | M | Stock Option (Right to Buy) | 30000 | $0.00 | 420,000.0000 | 106,114,000 | 6.67% | 0.03% |
| March 22, 2023 | Francois Cedric | Chief Executive Officer | M | Common Stock | 7221 | $13.85 | 1,806,223.0000 | 106,114,000 | 0.40% | 0.01% |
| March 21, 2023 | Francois Cedric | Chief Executive Officer | M | Common Stock | 30000 | $2.67 | 1,709,002.0000 | 106,114,000 | 1.79% | 0.03% |
| March 21, 2023 | Francois Cedric | Chief Executive Officer | S | Common Stock | 30000 | $62.74 | 1,679,002.0000 | 106,114,000 | 1.76% | 0.03% |
| March 22, 2023 | Francois Cedric | Chief Executive Officer | M | Common Stock | 20000 | $2.67 | 1,699,002.0000 | 106,114,000 | 1.19% | 0.02% |
| March 22, 2023 | Francois Cedric | Chief Executive Officer | M | Common Stock | 100000 | $3.76 | 1,799,002.0000 | 106,114,000 | 5.89% | 0.09% |
| March 17, 2023 | Machiels Alec | Director | M | Common Stock | 1250 | $2.67 | 680,841.0000 | 106,114,000 | 0.18% | 0.00% |
| March 17, 2023 | Machiels Alec | Director | M | Stock Option (Right to Buy) | 1250 | $0.00 | 109,779.0000 | 106,114,000 | 1.13% | 0.00% |
| March 17, 2023 | Machiels Alec | Director | S | Common Stock | 1250 | $64.03 | 679,591.0000 | 106,114,000 | 0.18% | 0.00% |
| March 8, 2023 | Deschatelets Pascal | Chief Scientific Officer | M | Common Stock | 18500 | $2.67 | 1,032,813.0000 | 106,114,000 | 1.82% | 0.02% |
| March 8, 2023 | Deschatelets Pascal | Chief Scientific Officer | S | Common Stock | 12000 | $63.79 | 1,020,813.0000 | 106,114,000 | 1.16% | 0.01% |
| March 8, 2023 | Deschatelets Pascal | Chief Scientific Officer | M | Stock Option (Right to Buy) | 18500 | $0.00 | 146,994.0000 | 106,114,000 | 11.18% | 0.02% |
| March 3, 2023 | Townsend Adam J. | Chief Commercial Officer | S | Common Stock | 5000 | $63.84 | 75,995.0000 | 106,114,000 | 6.17% | 0.00% |
| March 3, 2023 | Townsend Adam J. | Chief Commercial Officer | M | Stock Option (Right to Buy) | 5000 | $0.00 | 292,500.0000 | 106,114,000 | 1.68% | 0.00% |
| March 3, 2023 | Townsend Adam J. | Chief Commercial Officer | M | Common Stock | 5000 | $15.09 | 80,995.0000 | 106,114,000 | 6.58% | 0.00% |
| March 1, 2023 | Dunlop A. Sinclair | Director | S | Common Stock | 500 | $65.33 | 404,331.0000 | 106,114,000 | 0.12% | 0.00% |
| Feb. 27, 2023 | Francois Cedric | Chief Executive Officer | M | Stock Option (Right to Buy) | 100000 | $0.00 | 158,840.0000 | 106,114,000 | 38.63% | 0.09% |
| Feb. 27, 2023 | Francois Cedric | Chief Executive Officer | M | Common Stock | 100000 | $3.76 | 1,679,002.0000 | 106,114,000 | 6.33% | 0.09% |
| Feb. 23, 2023 | Eisele Jeffrey | Chief Development Officer | S | Common Stock | 1646 | $68.76 | 53,883.0000 | 106,114,000 | 2.96% | 0.00% |
| Feb. 23, 2023 | Lewis Karen | Chief People Officer | S | Common Stock | 1104 | $68.76 | 41,430.0000 | 106,114,000 | 2.60% | 0.00% |
| Feb. 21, 2023 | Sullivan Timothy Eugene | Chief Financial Officer | A | Stock Option (Right to Buy) | 16572 | $0.00 | 16,572.0000 | 106,114,000 | 9999.99% | 0.02% |
| Feb. 21, 2023 | Watson David O. | General Counsel | F | Common Stock | 825 | $58.50 | 184,968.0000 | 106,114,000 | 0.44% | 0.00% |
| Feb. 21, 2023 | Watson David O. | General Counsel | A | Stock Option (Right to Buy) | 14023 | $0.00 | 14,023.0000 | 106,114,000 | 9999.99% | 0.01% |
| Feb. 21, 2023 | Francois Cedric | Chief Executive Officer | A | Common Stock | 13908 | $0.00 | 1,580,604.0000 | 106,114,000 | 0.89% | 0.01% |
| Feb. 21, 2023 | Francois Cedric | Chief Executive Officer | F | Common Stock | 1602 | $58.50 | 1,579,002.0000 | 106,114,000 | 0.10% | 0.00% |
| Feb. 21, 2023 | Francois Cedric | Chief Executive Officer | A | Stock Option (Right to Buy) | 19728 | $0.00 | 19,728.0000 | 106,114,000 | 9999.99% | 0.02% |
| Feb. 21, 2023 | Townsend Adam J. | Chief Commercial Officer | A | Common Stock | 9886 | $0.00 | 77,036.0000 | 106,114,000 | 14.72% | 0.01% |
| Feb. 21, 2023 | Townsend Adam J. | Chief Commercial Officer | F | Common Stock | 1041 | $58.50 | 75,995.0000 | 106,114,000 | 1.35% | 0.00% |
| Feb. 21, 2023 | Townsend Adam J. | Chief Commercial Officer | A | Stock Option (Right to Buy) | 14023 | $0.00 | 14,023.0000 | 106,114,000 | 9999.99% | 0.01% |
| Feb. 21, 2023 | SCHEIBLER LUKAS | Chief Research Officer | A | Stock Option (Right to Buy) | 14023 | $0.00 | 14,023.0000 | 106,114,000 | 9999.99% | 0.01% |
| Feb. 21, 2023 | DeLong Mark Jeffrey | Chief Business & Strat Officer | A | Common Stock | 5280 | $0.00 | 51,782.0000 | 106,114,000 | 11.35% | 0.00% |
| Feb. 21, 2023 | DeLong Mark Jeffrey | Chief Business & Strat Officer | F | Common Stock | 441 | $58.50 | 51,341.0000 | 106,114,000 | 0.85% | 0.00% |
| Feb. 21, 2023 | DeLong Mark Jeffrey | Chief Business & Strat Officer | A | Stock Option (Right to Buy) | 7489 | $0.00 | 7,489.0000 | 106,114,000 | 9999.99% | 0.01% |
| Feb. 21, 2023 | Eisele Jeffrey | Chief Development Officer | A | Common Stock | 9886 | $0.00 | 56,354.0000 | 106,114,000 | 21.27% | 0.01% |
| Feb. 21, 2023 | Eisele Jeffrey | Chief Development Officer | F | Common Stock | 825 | $58.50 | 55,529.0000 | 106,114,000 | 1.46% | 0.00% |
| Feb. 21, 2023 | Eisele Jeffrey | Chief Development Officer | A | Stock Option (Right to Buy) | 14023 | $0.00 | 14,023.0000 | 106,114,000 | 9999.99% | 0.01% |
| Feb. 21, 2023 | Nicholson Nur | Chief Technical Officer | A | Common Stock | 9886 | $0.00 | 64,328.0000 | 106,114,000 | 18.16% | 0.01% |
| Feb. 21, 2023 | Nicholson Nur | Chief Technical Officer | F | Common Stock | 825 | $58.50 | 63,503.0000 | 106,114,000 | 1.28% | 0.00% |
| Feb. 21, 2023 | Nicholson Nur | Chief Technical Officer | A | Stock Option (Right to Buy) | 14023 | $0.00 | 14,023.0000 | 106,114,000 | 9999.99% | 0.01% |
| Feb. 21, 2023 | Chopas James George | VP/Chief Accounting Officer | A | Common Stock | 4044 | $0.00 | 31,197.0000 | 106,114,000 | 14.89% | 0.00% |
| Feb. 21, 2023 | Chopas James George | VP/Chief Accounting Officer | F | Common Stock | 334 | $58.50 | 30,863.0000 | 106,114,000 | 1.07% | 0.00% |
| Feb. 21, 2023 | Chopas James George | VP/Chief Accounting Officer | A | Stock Option (Right to Buy) | 5737 | $0.00 | 5,737.0000 | 106,114,000 | 9999.99% | 0.01% |
| Feb. 21, 2023 | Deschatelets Pascal | Chief Scientific Officer | A | Common Stock | 9886 | $0.00 | 1,015,508.0000 | 106,114,000 | 0.98% | 0.01% |
| Feb. 21, 2023 | Deschatelets Pascal | Chief Scientific Officer | F | Common Stock | 1195 | $58.50 | 1,014,313.0000 | 106,114,000 | 0.12% | 0.00% |
| Feb. 21, 2023 | Deschatelets Pascal | Chief Scientific Officer | A | Stock Option (Right to Buy) | 14023 | $0.00 | 14,023.0000 | 106,114,000 | 9999.99% | 0.01% |
| Feb. 21, 2023 | Sullivan Timothy Eugene | Chief Financial Officer | A | Common Stock | 11683 | $0.00 | 134,919.0000 | 106,114,000 | 9.48% | 0.01% |
| Feb. 21, 2023 | Sullivan Timothy Eugene | Chief Financial Officer | F | Common Stock | 974 | $58.50 | 133,945.0000 | 106,114,000 | 0.72% | 0.00% |
| Feb. 21, 2023 | Watson David O. | General Counsel | A | Common Stock | 9886 | $0.00 | 185,793.0000 | 106,114,000 | 5.62% | 0.01% |
| Feb. 21, 2023 | Lewis Karen | Chief People Officer | A | Common Stock | 6628 | $0.00 | 43,087.0000 | 106,114,000 | 18.18% | 0.01% |
| Feb. 21, 2023 | Lewis Karen | Chief People Officer | F | Common Stock | 553 | $58.50 | 42,534.0000 | 106,114,000 | 1.28% | 0.00% |
| Feb. 21, 2023 | Lewis Karen | Chief People Officer | A | Stock Option (Right to Buy) | 9402 | $0.00 | 9,402.0000 | 106,114,000 | 9999.99% | 0.01% |
| Feb. 21, 2023 | SCHEIBLER LUKAS | Chief Research Officer | A | Common Stock | 9886 | $0.00 | 70,358.0000 | 106,114,000 | 16.35% | 0.01% |
| Feb. 21, 2023 | SCHEIBLER LUKAS | Chief Research Officer | F | Common Stock | 715 | $58.50 | 69,643.0000 | 106,114,000 | 1.02% | 0.00% |
| Feb. 17, 2023 | Machiels Alec | Director | M | Common Stock | 1250 | $2.67 | 680,841.0000 | 106,114,000 | 0.18% | 0.00% |
| Feb. 17, 2023 | Machiels Alec | Director | S | Common Stock | 1250 | $52.38 | 679,591.0000 | 106,114,000 | 0.18% | 0.00% |
| Feb. 17, 2023 | Machiels Alec | Director | M | Stock Option (Right to Buy) | 1250 | $0.00 | 111,029.0000 | 106,114,000 | 1.11% | 0.00% |
| Feb. 10, 2023 | Francois Cedric | Chief Executive Officer | F | Common Stock | 3958 | $51.21 | 1,566,696.0000 | 106,114,000 | 0.25% | 0.00% |
| Feb. 10, 2023 | SCHEIBLER LUKAS | Chief Research Officer | F | Common Stock | 678 | $51.21 | 60,472.0000 | 106,114,000 | 1.11% | 0.00% |
| Feb. 10, 2023 | Sullivan Timothy Eugene | Chief Financial Officer | F | Common Stock | 975 | $51.21 | 123,236.0000 | 106,114,000 | 0.78% | 0.00% |
| Feb. 10, 2023 | Townsend Adam J. | Chief Commercial Officer | F | Common Stock | 782 | $51.21 | 67,150.0000 | 106,114,000 | 1.15% | 0.00% |
| Feb. 10, 2023 | Watson David O. | General Counsel | F | Common Stock | 532 | $51.21 | 175,907.0000 | 106,114,000 | 0.30% | 0.00% |
| Feb. 10, 2023 | DeLong Mark Jeffrey | Chief Business & Strat Officer | F | Common Stock | 670 | $51.21 | 46,502.0000 | 106,114,000 | 1.42% | 0.00% |
| Feb. 10, 2023 | Deschatelets Pascal | Chief Scientific Officer | F | Common Stock | 1134 | $51.21 | 1,005,622.0000 | 106,114,000 | 0.11% | 0.00% |
| Feb. 8, 2023 | Deschatelets Pascal | Chief Scientific Officer | M | Common Stock | 18500 | $2.67 | 1,018,756.0000 | 106,114,000 | 1.85% | 0.02% |
| Feb. 8, 2023 | Deschatelets Pascal | Chief Scientific Officer | M | Stock Option (Right to Buy) | 18500 | $0.00 | 165,494.0000 | 106,114,000 | 10.05% | 0.02% |
| Feb. 8, 2023 | Deschatelets Pascal | Chief Scientific Officer | S | Common Stock | 12000 | $54.45 | 1,006,756.0000 | 106,114,000 | 1.18% | 0.01% |
| Feb. 3, 2023 | Townsend Adam J. | Chief Commercial Officer | S | Common Stock | 5000 | $55.85 | 67,932.0000 | 106,114,000 | 6.86% | 0.00% |
| Feb. 3, 2023 | Townsend Adam J. | Chief Commercial Officer | M | Stock Option (Right to Buy) | 5000 | $0.00 | 297,500.0000 | 106,114,000 | 1.65% | 0.00% |
| Feb. 3, 2023 | Townsend Adam J. | Chief Commercial Officer | M | Common Stock | 5000 | $15.09 | 72,932.0000 | 106,114,000 | 7.36% | 0.00% |
| Feb. 1, 2023 | Dunlop A. Sinclair | Director | S | Common Stock | 500 | $52.61 | 404,831.0000 | 106,114,000 | 0.12% | 0.00% |
| Jan. 30, 2023 | Lewis Karen | Chief People Officer | S | Common Stock | 883 | $52.76 | 36,459.0000 | 106,114,000 | 2.36% | 0.00% |
| Jan. 30, 2023 | Eisele Jeffrey | Chief Development Officer | S | Common Stock | 883 | $52.76 | 46,468.0000 | 106,114,000 | 1.86% | 0.00% |
| Jan. 27, 2023 | Townsend Adam J. | Chief Commercial Officer | F | Common Stock | 551 | $52.77 | 67,932.0000 | 106,114,000 | 0.80% | 0.00% |
| Jan. 27, 2023 | Watson David O. | General Counsel | F | Common Stock | 551 | $52.77 | 176,439.0000 | 106,114,000 | 0.31% | 0.00% |
| Jan. 27, 2023 | Sullivan Timothy Eugene | Chief Financial Officer | F | Common Stock | 551 | $52.77 | 124,211.0000 | 106,114,000 | 0.44% | 0.00% |
| Jan. 27, 2023 | SCHEIBLER LUKAS | Chief Research Officer | F | Common Stock | 542 | $52.77 | 61,150.0000 | 106,114,000 | 0.88% | 0.00% |
| Jan. 27, 2023 | Nicholson Nur | Chief Technical Officer | F | Common Stock | 551 | $52.77 | 54,442.0000 | 106,114,000 | 1.00% | 0.00% |
| Jan. 27, 2023 | Lewis Karen | Chief People Officer | F | Common Stock | 367 | $52.77 | 37,342.0000 | 106,114,000 | 0.97% | 0.00% |
| Jan. 27, 2023 | Francois Cedric | Chief Executive Officer | F | Common Stock | 2879 | $52.77 | 1,570,654.0000 | 106,114,000 | 0.18% | 0.00% |
| Jan. 27, 2023 | Eisele Jeffrey | Chief Development Officer | F | Common Stock | 367 | $52.77 | 47,351.0000 | 106,114,000 | 0.77% | 0.00% |
| Jan. 27, 2023 | Deschatelets Pascal | Chief Scientific Officer | F | Common Stock | 832 | $52.77 | 1,000,256.0000 | 106,114,000 | 0.08% | 0.00% |
| Jan. 27, 2023 | DeLong Mark Jeffrey | Chief Business & Strat Officer | F | Common Stock | 367 | $52.77 | 47,172.0000 | 106,114,000 | 0.77% | 0.00% |
| Jan. 23, 2023 | Eisele Jeffrey | Chief Development Officer | S | Common Stock | 4479 | $51.58 | 47,718.0000 | 106,114,000 | 8.58% | 0.00% |
| Jan. 23, 2023 | Lewis Karen | Chief People Officer | S | Common Stock | 2955 | $51.58 | 37,709.0000 | 106,114,000 | 7.27% | 0.00% |
| Jan. 20, 2023 | Townsend Adam J. | Chief Commercial Officer | F | Common Stock | 1912 | $52.05 | 68,483.0000 | 106,114,000 | 2.72% | 0.00% |
| Jan. 20, 2023 | Sullivan Timothy Eugene | Chief Financial Officer | F | Common Stock | 2379 | $52.05 | 124,762.0000 | 106,114,000 | 1.87% | 0.00% |
| Jan. 20, 2023 | SCHEIBLER LUKAS | Chief Research Officer | F | Common Stock | 2015 | $52.05 | 61,692.0000 | 106,114,000 | 3.16% | 0.00% |
| Jan. 20, 2023 | Nicholson Nur | Chief Technical Officer | F | Common Stock | 2034 | $52.05 | 54,993.0000 | 106,114,000 | 3.57% | 0.00% |
| Jan. 20, 2023 | Lewis Karen | Chief People Officer | F | Common Stock | 1411 | $52.05 | 40,664.0000 | 106,114,000 | 3.35% | 0.00% |
| Jan. 20, 2023 | Francois Cedric | Chief Executive Officer | F | Common Stock | 9453 | $52.05 | 1,573,533.0000 | 106,114,000 | 0.60% | 0.01% |
| Jan. 20, 2023 | Eisele Jeffrey | Chief Development Officer | F | Common Stock | 2033 | $52.05 | 52,197.0000 | 106,114,000 | 3.75% | 0.00% |
| Jan. 20, 2023 | Deschatelets Pascal | Chief Scientific Officer | F | Common Stock | 2326 | $52.05 | 1,001,088.0000 | 106,114,000 | 0.23% | 0.00% |
| Jan. 20, 2023 | DeLong Mark Jeffrey | Chief Business & Strat Officer | F | Common Stock | 1149 | $52.05 | 47,539.0000 | 106,114,000 | 2.36% | 0.00% |
| Jan. 20, 2023 | Brown Victoria L. | Program Team Lead | F | Common Stock | 1412 | $52.05 | 23,556.0000 | 106,114,000 | 5.66% | 0.00% |
| Jan. 20, 2023 | Chopas James George | VP/Chief Accounting Officer | F | Common Stock | 919 | $52.05 | 27,153.0000 | 106,114,000 | 3.27% | 0.00% |
| Jan. 20, 2023 | Watson David O. | General Counsel | F | Common Stock | 2034 | $52.05 | 176,990.0000 | 106,114,000 | 1.14% | 0.00% |
| Jan. 17, 2023 | Machiels Alec | Director | S | Common Stock | 1250 | $52.42 | 679,591.0000 | 106,114,000 | 0.18% | 0.00% |
| Jan. 17, 2023 | Machiels Alec | Director | M | Common Stock | 1250 | $2.67 | 680,841.0000 | 106,114,000 | 0.18% | 0.00% |
| Jan. 17, 2023 | Machiels Alec | Director | M | Stock Option (Right to Buy) | 1250 | $0.00 | 112,279.0000 | 106,114,000 | 1.10% | 0.00% |
| Jan. 12, 2023 | Townsend Adam J. | Chief Commercial Officer | A | Stock Option (Right to Buy) | 43183 | $52.66 | 43,183.0000 | 106,114,000 | 9999.99% | 0.04% |
| April 25, 2022 | Francois Cedric | Chief Executive Officer | J | Stock Option (Right to Buy) | 75000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Jan. 12, 2023 | Francois Cedric | Chief Executive Officer | A | Common Stock | 83447 | $0.00 | 1,582,986.0000 | 106,114,000 | 5.56% | 0.08% |
| Jan. 12, 2023 | Lewis Karen | Chief People Officer | A | Stock Option (Right to Buy) | 30845 | $52.66 | 30,845.0000 | 106,114,000 | 9999.99% | 0.03% |
| April 25, 2022 | Lewis Karen | Chief People Officer | J | Stock Option (Right to Buy) | 7500 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Jan. 12, 2023 | Lewis Karen | Chief People Officer | A | Common Stock | 19634 | $0.00 | 42,075.0000 | 106,114,000 | 87.49% | 0.02% |
| April 25, 2022 | Lewis Karen | Chief People Officer | J | Common Stock | 1250 | $0.00 | 22,224.0000 | 0 | 5.33% | 0.00% |
| Jan. 12, 2023 | Nicholson Nur | Chief Technical Officer | A | Stock Option (Right to Buy) | 35472 | $52.66 | 35,472.0000 | 106,114,000 | 9999.99% | 0.03% |
| April 25, 2022 | Nicholson Nur | Chief Technical Officer | J | Stock Option (Right to Buy) | 11250 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Jan. 12, 2023 | Nicholson Nur | Chief Technical Officer | A | Common Stock | 22580 | $0.00 | 57,027.0000 | 106,114,000 | 65.55% | 0.02% |
| April 25, 2022 | Nicholson Nur | Chief Technical Officer | J | Common Stock | 1875 | $0.00 | 33,680.0000 | 0 | 5.27% | 0.00% |
| Jan. 12, 2023 | SCHEIBLER LUKAS | Chief Research Officer | A | Stock Option (Right to Buy) | 35472 | $52.66 | 35,472.0000 | 106,114,000 | 9999.99% | 0.03% |
| Jan. 12, 2023 | SCHEIBLER LUKAS | Chief Research Officer | A | Common Stock | 22580 | $0.00 | 63,707.0000 | 106,114,000 | 54.90% | 0.02% |
| Jan. 12, 2023 | Townsend Adam J. | Chief Commercial Officer | A | Common Stock | 27488 | $0.00 | 70,395.0000 | 106,114,000 | 64.06% | 0.03% |
| Jan. 12, 2023 | Watson David O. | General Counsel | A | Stock Option (Right to Buy) | 37708 | $52.66 | 37,708.0000 | 106,114,000 | 9999.99% | 0.04% |
| Jan. 12, 2023 | Watson David O. | General Counsel | A | Common Stock | 29452 | $0.00 | 179,024.0000 | 106,114,000 | 19.69% | 0.03% |
| Jan. 12, 2023 | Watson David O. | General Counsel | A | Common Stock | 24003 | $0.00 | 149,572.0000 | 106,114,000 | 19.12% | 0.02% |
| Jan. 12, 2023 | Sullivan Timothy Eugene | Chief Financial Officer | A | Stock Option (Right to Buy) | 43183 | $52.66 | 43,183.0000 | 106,114,000 | 9999.99% | 0.04% |
| April 25, 2022 | Sullivan Timothy Eugene | Chief Financial Officer | J | Stock Option (Right to Buy) | 22500 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Jan. 12, 2023 | Sullivan Timothy Eugene | Chief Financial Officer | A | Common Stock | 27488 | $0.00 | 127,141.0000 | 106,114,000 | 27.58% | 0.03% |
| April 25, 2022 | Sullivan Timothy Eugene | Chief Financial Officer | J | Common Stock | 3750 | $0.00 | 99,653.0000 | 0 | 3.63% | 0.00% |
| Jan. 12, 2023 | Chopas James George | VP/Chief Accounting Officer | A | Stock Option (Right to Buy) | 15114 | $52.66 | 15,114.0000 | 106,114,000 | 9999.99% | 0.01% |
| Jan. 12, 2023 | Chopas James George | VP/Chief Accounting Officer | A | Common Stock | 9621 | $0.00 | 28,072.0000 | 106,114,000 | 52.14% | 0.01% |
| Jan. 12, 2023 | DeLong Mark Jeffrey | Chief Business & Strat Officer | A | Stock Option (Right to Buy) | 30845 | $52.66 | 30,845.0000 | 106,114,000 | 9999.99% | 0.03% |
| Jan. 12, 2023 | DeLong Mark Jeffrey | Chief Business & Strat Officer | A | Common Stock | 19634 | $0.00 | 48,688.0000 | 106,114,000 | 67.58% | 0.02% |
| Jan. 12, 2023 | Deschatelets Pascal | Chief Scientific Officer | A | Stock Option (Right to Buy) | 30845 | $52.66 | 30,845.0000 | 106,114,000 | 9999.99% | 0.03% |
| Jan. 12, 2023 | Deschatelets Pascal | Chief Scientific Officer | A | Common Stock | 19634 | $0.00 | 1,003,414.0000 | 106,114,000 | 2.00% | 0.02% |
| Jan. 12, 2023 | Eisele Jeffrey | Chief Development Officer | A | Stock Option (Right to Buy) | 35472 | $52.66 | 35,472.0000 | 106,114,000 | 9999.99% | 0.03% |
| Jan. 12, 2023 | Eisele Jeffrey | Chief Development Officer | A | Common Stock | 22580 | $0.00 | 54,230.0000 | 106,114,000 | 71.34% | 0.02% |
| Jan. 12, 2023 | Francois Cedric | Chief Executive Officer | A | Stock Option (Right to Buy) | 131093 | $52.66 | 131,093.0000 | 106,114,000 | 9999.99% | 0.12% |
| Jan. 9, 2023 | Deschatelets Pascal | Chief Scientific Officer | S | Common Stock | 12000 | $46.08 | 983,780.0000 | 106,114,000 | 1.21% | 0.01% |
| Jan. 9, 2023 | Deschatelets Pascal | Chief Scientific Officer | M | Stock Option (Right to Buy) | 18500 | $0.00 | 183,994.0000 | 106,114,000 | 9.14% | 0.02% |
| Jan. 9, 2023 | Deschatelets Pascal | Chief Scientific Officer | M | Common Stock | 18500 | $2.67 | 995,780.0000 | 106,114,000 | 1.89% | 0.02% |
| Jan. 5, 2023 | Grossi Federico | Chief Medical Officer | S | Common Stock | 2500 | $48.79 | 94,884.0000 | 106,114,000 | 2.57% | 0.00% |
| Jan. 3, 2023 | Baumal Caroline | Chief Medical Officer | A | Common Stock | 35549 | $0.00 | 35,682.3700 | 106,114,000 | 9999.99% | 0.03% |
| Jan. 3, 2023 | Baumal Caroline | Chief Medical Officer | A | Stock Option (Right to Buy) | 49000 | $50.28 | 49,000.0000 | 106,114,000 | 9999.99% | 0.05% |
| Jan. 3, 2023 | Dunlop A. Sinclair | Director | S | Common Stock | 500 | $50.70 | 405,331.0000 | 106,114,000 | 0.12% | 0.00% |
| Jan. 3, 2023 | Townsend Adam J. | Chief Commercial Officer | M | Common Stock | 5000 | $15.09 | 47,907.0000 | 106,114,000 | 11.65% | 0.00% |
| Jan. 3, 2023 | Townsend Adam J. | Chief Commercial Officer | S | Common Stock | 5000 | $50.70 | 42,907.0000 | 106,114,000 | 10.44% | 0.00% |
| Jan. 3, 2023 | Townsend Adam J. | Chief Commercial Officer | M | Stock Option (Right to Buy) | 5000 | $0.00 | 302,500.0000 | 106,114,000 | 1.63% | 0.00% |
| Jan. 1, 2023 | O'Brien Stephanie Monaghan | Director | A | Common Stock | 3867 | $0.00 | 8,097.0000 | 106,114,000 | 91.42% | 0.00% |
| Jan. 1, 2023 | Dunlop A. Sinclair | Director | A | Stock Option (Right to Buy) | 7441 | $0.00 | 7,441.0000 | 106,114,000 | 9999.99% | 0.01% |
| Jan. 1, 2023 | Dunlop A. Sinclair | Director | A | Common Stock | 3867 | $0.00 | 405,831.0000 | 106,114,000 | 0.96% | 0.00% |
| Jan. 1, 2023 | Machiels Alec | Director | A | Stock Option (Right to Buy) | 7441 | $0.00 | 7,441.0000 | 106,114,000 | 9999.99% | 0.01% |
| Jan. 1, 2023 | FONTEYNE PAUL R. | Director | A | Common Stock | 3867 | $0.00 | 13,097.0000 | 106,114,000 | 41.90% | 0.00% |
| Jan. 1, 2023 | Machiels Alec | Director | A | Common Stock | 3867 | $0.00 | 679,591.0000 | 106,114,000 | 0.57% | 0.00% |
| Jan. 1, 2023 | FONTEYNE PAUL R. | Director | A | Stock Option (Right to Buy) | 7441 | $0.00 | 7,441.0000 | 106,114,000 | 9999.99% | 0.01% |
| Jan. 1, 2023 | Chan Gerald | Director | A | Stock Option (Right to Buy) | 7441 | $0.00 | 7,441.0000 | 106,114,000 | 9999.99% | 0.01% |
| Jan. 1, 2023 | Chan Gerald | Director | A | Common Stock | 3867 | $0.00 | 8,097.0000 | 106,114,000 | 91.42% | 0.00% |
| Jan. 1, 2023 | O'Brien Stephanie Monaghan | Director | A | Stock Option (Right to Buy) | 7441 | $0.00 | 7,441.0000 | 106,114,000 | 9999.99% | 0.01% |